Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1986 Aug;67:201–282. doi: 10.1289/ehp.67-1474412

Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens.

PMCID: PMC1474412  PMID: 3530737

Abstract

In order to articulate a view of chemical carcinogenesis that scientists generally hold in common today and to draw upon this understanding to compose guiding principles that can be used as a bases for the efforts of the regulatory agencies to establish guidelines for assessing carcinogenic risk to meet the specific requirements of the legislative acts they are charged to implement, the Office of Science and Technology Policy, Executive Office, the White House drew on the expertise of a number of regulatory agencies to elucidate present scientific views in critical areas of the major disciplines important to the process of risk assessment. The document is composed of two major sections, Principles and the State-of-the-Science. The latter consists of subsections on the mechanisms of carcinogenesis, short-term and long-term testing, and epidemiology, which are important components in the risk assessment step of hazard identification. These subsections are followed by one on exposure assessment, and a final section which includes analyses of dose-response (hazard) assessment and risk characterization. The principles are derived from considerations in each of the subsections. Because of present gaps in understanding, the principles contain judgmental (science policy) decisions on major unresolved issues as well as statements of what is generally accepted as fact. These judgments are basically assumptions which are responsible for much of the uncertainty in the process of risk assessment. There was an attempt to clearly distinguish policy and fact. The subsections of the State-of-the-Science portion provide the underlying support to the principles articulated, and to read the "Principles" section without a full appreciation of the State-of-the-Science section is to invite oversimplification and misinterpretation. Finally, suggestions are made for future research efforts which will improve the process of risk assessment.

Full text

PDF
201

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abo-Darub J. M., Mackie R., Pitts J. D. DNA repair deficiency in lymphocytes from patients with actinic keratosis. Bull Cancer. 1978;65(3):357–362. [PubMed] [Google Scholar]
  2. Ames B. N. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science. 1983 Sep 23;221(4617):1256–1264. doi: 10.1126/science.6351251. [DOI] [PubMed] [Google Scholar]
  3. Ames B. N., Durston W. E., Yamasaki E., Lee F. D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci U S A. 1973 Aug;70(8):2281–2285. doi: 10.1073/pnas.70.8.2281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anderson M. W., Hoel D. G., Kaplan N. L. A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chloride. Toxicol Appl Pharmacol. 1980 Aug;55(1):154–161. doi: 10.1016/0041-008x(80)90231-8. [DOI] [PubMed] [Google Scholar]
  5. Arlett C. F., Lehmann A. R. Human disorders showing increased sensitivity to the induction of genetic damage. Annu Rev Genet. 1978;12:95–115. doi: 10.1146/annurev.ge.12.120178.000523. [DOI] [PubMed] [Google Scholar]
  6. Armelin H. A., Armelin M. C., Kelly K., Stewart T., Leder P., Cochran B. H., Stiles C. D. Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature. 1984 Aug 23;310(5979):655–660. doi: 10.1038/310655a0. [DOI] [PubMed] [Google Scholar]
  7. Ashby J. The unique role of rodents in the detection of possible human carcinogens and mutagens. Mutat Res. 1983 Jun;115(2):177–213. doi: 10.1016/0165-1110(83)90003-9. [DOI] [PubMed] [Google Scholar]
  8. Austin D. F., Roe K. M. The decreasing incidence of endometrial cancer: public health implications. Am J Public Health. 1982 Jan;72(1):65–68. doi: 10.2105/ajph.72.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. BOUTWELL R. K. SOME BIOLOGICAL ASPECTS OF SKIN CARCINOGENISIS. Prog Exp Tumor Res. 1964;4:207–250. doi: 10.1159/000385978. [DOI] [PubMed] [Google Scholar]
  10. BURDETTE W. J. The significance of mutation in relation to the origin of tumors: a review. Cancer Res. 1955 May;15(4):201–226. [PubMed] [Google Scholar]
  11. Barker W. C., Dayhoff M. O. Viral src gene products are related to the catalytic chain of mammalian cAMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1982 May;79(9):2836–2839. doi: 10.1073/pnas.79.9.2836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bartram C. R., de Klein A., Hagemeijer A., van Agthoven T., Geurts van Kessel A., Bootsma D., Grosveld G., Ferguson-Smith M. A., Davies T., Stone M. Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature. 1983 Nov 17;306(5940):277–280. doi: 10.1038/306277a0. [DOI] [PubMed] [Google Scholar]
  13. Bartsch H., Malaveille C., Camus A. M., Martel-Planche G., Brun G., Hautefeuille A., Sabadie N., Barbin A., Kuroki T., Drevon C. Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems. Mutat Res. 1980 Jul;76(1):1–50. doi: 10.1016/0165-1110(80)90002-0. [DOI] [PubMed] [Google Scholar]
  14. Battula N., Loeb L. A. The infidelity of avian myeloblastosis virus deoxyribonucleic acid polymerase in polynucleotide replication. J Biol Chem. 1974 Jul 10;249(13):4086–4093. [PubMed] [Google Scholar]
  15. Berenbaum M. C. Criteria for analyzing interactions between biologically active agents. Adv Cancer Res. 1981;35:269–335. doi: 10.1016/s0065-230x(08)60912-4. [DOI] [PubMed] [Google Scholar]
  16. Bernstein L., Gold L. S., Ames B. N., Pike M. C., Hoel D. G. Some tautologous aspects of the comparison of carcinogenic potency in rats and mice. Fundam Appl Toxicol. 1985 Feb;5(1):79–86. doi: 10.1016/0272-0590(85)90051-x. [DOI] [PubMed] [Google Scholar]
  17. Bernstein L., Kaldor J., McCann J., Pike M. C. An empirical approach to the statistical analysis of mutagenesis data from the Salmonella test. Mutat Res. 1982 Aug;97(4):267–281. doi: 10.1016/0165-1161(82)90026-7. [DOI] [PubMed] [Google Scholar]
  18. Birnboim H. C. DNA strand breakage in human leukocytes exposed to a tumor promoter, phorbol myristate acetate. Science. 1982 Mar 5;215(4537):1247–1249. doi: 10.1126/science.6276978. [DOI] [PubMed] [Google Scholar]
  19. Bishop J. M. Retroviruses and cancer genes. Adv Cancer Res. 1982;37:1–32. doi: 10.1016/s0065-230x(08)60880-5. [DOI] [PubMed] [Google Scholar]
  20. Blair D. G., McClements W. L., Oskarsson M. K., Fischinger P. J., Vande Woude G. F. Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3504–3508. doi: 10.1073/pnas.77.6.3504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Blair D. G., Oskarsson M., Wood T. G., McClements W. L., Fischinger P. J., Vande Woude G. G. Activation of the transforming potential of a normal cell sequence: a molecular model for oncogenesis. Science. 1981 May 22;212(4497):941–943. doi: 10.1126/science.7233190. [DOI] [PubMed] [Google Scholar]
  22. Bogden J. M., Eastman A., Bresnick E. A system in mouse liver for the repair of O6-methylguanine lesions in methylated DNA. Nucleic Acids Res. 1981 Jul 10;9(13):3089–3103. doi: 10.1093/nar/9.13.3089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Borek C. Radiation oncogenesis in cell culture. Adv Cancer Res. 1982;37:159–232. doi: 10.1016/s0065-230x(08)60884-2. [DOI] [PubMed] [Google Scholar]
  24. Borek C., Troll W. Modifiers of free radicals inhibit in vitro the oncogenic actions of x-rays, bleomycin, and the tumor promoter 12-O-tetradecanoylphorbol 13-acetate. Proc Natl Acad Sci U S A. 1983 Mar;80(5):1304–1307. doi: 10.1073/pnas.80.5.1304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Bowden G. T., Giesselbach B., Fusenig N. E. Postreplication repair of DNA in ultraviolet light-irradiated normal and malignancy transformed mouse epidermal cell cultures. Cancer Res. 1978 Sep;38(9):2709–2718. [PubMed] [Google Scholar]
  26. Bradley M. O., Bhuyan B., Francis M. C., Langenbach R., Peterson A., Huberman E. Mutagenesis by chemical agents in V79 chinese hamster cells: a review and analysis of the literature. A report of the Gene-Tox Program. Mutat Res. 1981 Sep;87(2):81–142. doi: 10.1016/0165-1110(81)90029-4. [DOI] [PubMed] [Google Scholar]
  27. Brand K. G., Buoen L. C., Johnson K. H., Brand I. Etiological factors, stages, and the role of the foreign body in foreign body tumorigenesis: a review. Cancer Res. 1975 Feb;35(2):279–286. [PubMed] [Google Scholar]
  28. Brash D. E., Hart R. W. DNA damage and repair in vivo. J Environ Pathol Toxicol. 1978 Sep-Oct;2(1):79–114. [PubMed] [Google Scholar]
  29. Breimer L., Lindahl T. A DNA glycosylase from Escherichia coli that releases free urea from a polydeoxyribonucleotide containing fragments of base residues. Nucleic Acids Res. 1980 Dec 20;8(24):6199–6211. doi: 10.1093/nar/8.24.6199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Brooks A. L., Benjamin S. A., Jones R. K., McClellan R. O. Interaction of 144Ce and partial hepatectomy in the production of liver neoplasms in the Chinese hamster. Radiat Res. 1982 Sep;91(3):573–588. [PubMed] [Google Scholar]
  31. Brown H. S., Jeffrey A. M., Weinstein I. B. Formation of DNA adducts in 10T1/2 mouse embryo fibroblasts incubated with benzo(a)pyrene or dihydrodiol oxide derivatives. Cancer Res. 1979 May;39(5):1673–1677. [PubMed] [Google Scholar]
  32. Brungs W. A., McCormick J. H., Neiheisel T. W., Spehar R. L., Stephan C. E., Stokes G. N. Effects of pollution on freshwater fish. J Water Pollut Control Fed. 1977 Jun;49(6):1425–1493. [PubMed] [Google Scholar]
  33. Brusick D. J., Simmon V. F., Rosenkranz H. S., Ray V. A., Stafford R. S. An evaluation of the Escherichia coli WP2 and WP2 uvrA reverse mutation assay. Mutat Res. 1980 Sep;76(2):169–190. doi: 10.1016/0165-1110(80)90009-3. [DOI] [PubMed] [Google Scholar]
  34. Burnet F. M. Intrinsic mutagenesis: a genetic basis of ageing. Pathology. 1974 Jan;6(1):1–11. doi: 10.3109/00313027409077150. [DOI] [PubMed] [Google Scholar]
  35. Burrows P. D., Beck-Engeser G. B., Wabl M. R. Immunoglobulin heavy-chain class switching in a pre-B cell line is accompanied by DNA rearrangement. Nature. 1983 Nov 17;306(5940):243–246. doi: 10.1038/306243a0. [DOI] [PubMed] [Google Scholar]
  36. CONNEY A. H., MILLER E. C., MILLER J. A. The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res. 1956 Jun;16(5):450–459. [PubMed] [Google Scholar]
  37. Cairns J. The origin of human cancers. Nature. 1981 Jan 29;289(5796):353–357. doi: 10.1038/289353a0. [DOI] [PubMed] [Google Scholar]
  38. Caldwell J. Conjugation reactions in foreign-compound metabolism: definition, consequences, and species variations. Drug Metab Rev. 1982;13(5):745–777. doi: 10.3109/03602538208991360. [DOI] [PubMed] [Google Scholar]
  39. Carcinogen policy at EPA. Science. 1983 Feb 18;219(4586):794–798. [PubMed] [Google Scholar]
  40. Carroll K. K. Lipids and carcinogenesis. J Environ Pathol Toxicol. 1980 Mar;3(4 Spec No):253–271. [PubMed] [Google Scholar]
  41. Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U., Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem. 1982 Jul 10;257(13):7847–7851. [PubMed] [Google Scholar]
  42. Cerniglia C. E., Freeman J. P., Franklin W., Pack L. D. Metabolism of azo dyes derived from benzidine, 3,3'-dimethyl-benzidine and 3,3'-dimethoxybenzidine to potentially carcinogenic aromatic amines by intestinal bacteria. Carcinogenesis. 1982;3(11):1255–1260. doi: 10.1093/carcin/3.11.1255. [DOI] [PubMed] [Google Scholar]
  43. Cerniglia C. E., Freeman J. P., Franklin W., Pack L. D. Metabolism of benzidine and benzidine-congener based dyes by human, monkey and rat intestinal bacteria. Biochem Biophys Res Commun. 1982 Aug 31;107(4):1224–1229. doi: 10.1016/s0006-291x(82)80128-9. [DOI] [PubMed] [Google Scholar]
  44. Cerutti P., Shinohara K., Remsen J. Repair of DNA damage induced by ionizing radiation and benzo[a]pyrene in mammalian cells. J Toxicol Environ Health. 1977 Jul;2(6):1375–1386. doi: 10.1080/15287397709529537. [DOI] [PubMed] [Google Scholar]
  45. Chiou C. T., Schmedding D. W., Block J. H. Correlation of water solubility with octanol-water partition coefficient. J Pharm Sci. 1981 Oct;70(10):1176–1177. doi: 10.1002/jps.2600701027. [DOI] [PubMed] [Google Scholar]
  46. Chu K. C., Cueto C., Jr, Ward J. M. Factors in the evaluation of 200 National Cancer Institute carcinogen bioassays. J Toxicol Environ Health. 1981 Jul-Aug;8(1-2):251–280. doi: 10.1080/15287398109530068. [DOI] [PubMed] [Google Scholar]
  47. Clarkson B. D., Fried J., Chou T. C., Strife A., Ferguson R., Sullivan S., Kitahara T., Oyama A. Duration of the dormant state in an established cell line of human hematopoietic cells. Cancer Res. 1977 Dec;37(12):4506–4522. [PubMed] [Google Scholar]
  48. Clarkson B., Strife A., De Harven E. Continuous culture of seven new cell lines (SK-L1 to 7) from patients with acute leukemia. Cancer. 1967 Jun;20(6):926–947. doi: 10.1002/1097-0142(196706)20:6<926::aid-cncr2820200603>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  49. Cleaver J. E. Defective repair replication of DNA in xeroderma pigmentosum. Nature. 1968 May 18;218(5142):652–656. doi: 10.1038/218652a0. [DOI] [PubMed] [Google Scholar]
  50. Cleaver J. E., Thomas G. H., Trosko J. E., Lett J. T. Excision repair (dimer excision, strand breakage and repair replication) in primary cultures of eukaryotic (bovine) cells. Exp Cell Res. 1972 Sep;74(1):67–80. doi: 10.1016/0014-4827(72)90482-x. [DOI] [PubMed] [Google Scholar]
  51. Clive D., McCuen R., Spector J. F., Piper C., Mavournin K. H. Specific gene mutations in L5178Y cells in culture. Mutat Res. 1983 Jun;115(2):225–251. doi: 10.1016/0165-1110(83)90005-2. [DOI] [PubMed] [Google Scholar]
  52. Coffin J. M., Varmus H. E., Bishop J. M., Essex M., Hardy W. D., Jr, Martin G. S., Rosenberg N. E., Scolnick E. M., Weinberg R. A., Vogt P. K. Proposal for naming host cell-derived inserts in retrovirus genomes. J Virol. 1981 Dec;40(3):953–957. doi: 10.1128/jvi.40.3.953-957.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Cole A., Shonka F., Corry P., Cooper W. G. CHO cell repair of single-strand and double-strand DNA breaks induced by gamma- and alpha-radiations. Basic Life Sci. 1975;5B:665–676. doi: 10.1007/978-1-4684-2898-8_40. [DOI] [PubMed] [Google Scholar]
  54. Conney A. H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res. 1982 Dec;42(12):4875–4917. [PubMed] [Google Scholar]
  55. Cooke A., Johnson B. E. Dose response, wavelength dependence and rate of excision of ultraviolet radiation-induced pyrimidine dimers in mouse skin DNA. Biochim Biophys Acta. 1978 Jan 26;517(1):24–30. doi: 10.1016/0005-2787(78)90030-8. [DOI] [PubMed] [Google Scholar]
  56. Cooper G. M., Neiman P. E. Transforming genes of neoplasms induced by avian lymphoid leukosis viruses. Nature. 1980 Oct 16;287(5783):656–659. doi: 10.1038/287656a0. [DOI] [PubMed] [Google Scholar]
  57. Cooper G. M., Okenquist S., Silverman L. Transforming activity of DNA of chemically transformed and normal cells. Nature. 1980 Apr 3;284(5755):418–421. doi: 10.1038/284418a0. [DOI] [PubMed] [Google Scholar]
  58. Cooper G. M. The 1984 Walter Hubert lecture. Activation of transforming genes in neoplasms. Br J Cancer. 1984 Aug;50(2):137–142. doi: 10.1038/bjc.1984.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Corry P. M., Cole A. Double strand rejoining in mammalian DNA. Nat New Biol. 1973 Sep 26;245(143):100–101. [PubMed] [Google Scholar]
  60. Craddock V. M., Henderson A. R. The activity of 3-methyladenine DNA glycosylate in animal tissues in relation to carcinogenesis. Carcinogenesis. 1982;3(7):747–750. doi: 10.1093/carcin/3.7.747. [DOI] [PubMed] [Google Scholar]
  61. Crouch E., Wilson R. Interspecies comparison of carcionogenic potency. J Toxicol Environ Health. 1979 Nov;5(6):1095–1118. doi: 10.1080/15287397909529817. [DOI] [PubMed] [Google Scholar]
  62. Crump K. S., Hoel D. G., Langley C. H., Peto R. Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 1976 Sep;36(9 PT1):2973–2979. [PubMed] [Google Scholar]
  63. D'Ambrosio S. M., Setlow R. B. Enhancement of postreplication repair in Chinese hamster cells. Proc Natl Acad Sci U S A. 1976 Jul;73(7):2396–2400. doi: 10.1073/pnas.73.7.2396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. D'Ambrosio S. M., Whetstone J. W., Slazinski L., Lowney E. Photorepair of pyrimidine dimers in human skin in vivo. Photochem Photobiol. 1981 Oct;34(4):461–464. [PubMed] [Google Scholar]
  65. DULBECCO R. Experiments on photoreactivation of bacteriophages inactivated with ultraviolet radiation. J Bacteriol. 1950 Mar;59(3):329–347. doi: 10.1128/jb.59.3.329-347.1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Dahl A. R., Hadley W. M., Hahn F. F., Benson J. M., McClellan R. O. Cytochrome P-450-dependent monooxygenases in olfactory epithelium of dogs: possible role in tumorigenicity. Science. 1982 Apr 2;216(4541):57–59. doi: 10.1126/science.7063870. [DOI] [PubMed] [Google Scholar]
  67. Dalla-Favera R., Franchini G., Martinotti S., Wong-Staal F., Gallo R. C., Croce C. M. Chromosomal assignment of the human homologues of feline sarcoma virus and avian myeloblastosis virus onc genes. Proc Natl Acad Sci U S A. 1982 Aug;79(15):4714–4717. doi: 10.1073/pnas.79.15.4714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Dalla-Favera R., Gelmann E. P., Gallo R. C., Wong-Staal F. A human onc gene homologous to the transforming gene (v-sis) of simian sarcoma virus. Nature. 1981 Jul 2;292(5818):31–35. doi: 10.1038/292031a0. [DOI] [PubMed] [Google Scholar]
  69. Darnell J. E., Jr Variety in the level of gene control in eukaryotic cells. Nature. 1982 Jun 3;297(5865):365–371. doi: 10.1038/297365a0. [DOI] [PubMed] [Google Scholar]
  70. Day N. E., Brown C. C. Multistage models and primary prevention of cancer. J Natl Cancer Inst. 1980 Apr;64(4):977–989. [PubMed] [Google Scholar]
  71. Dayton P. G., Sanders J. E. Dose-dependent pharmacokinetics: emphasis on phase I metabolism. Drug Metab Rev. 1983;14(3):347–405. doi: 10.3109/03602538308991394. [DOI] [PubMed] [Google Scholar]
  72. DeFeo D., Gonda M. A., Young H. A., Chang E. H., Lowy D. R., Scolnick E. M., Ellis R. W. Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3328–3332. doi: 10.1073/pnas.78.6.3328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Debuire B., Henry C., Bernissa M., Biserte G., Claverie J. M., Saule S., Martin P., Stehelin D. Sequencing the erbA gene of avian erythroblastosis virus reveals a new type of oncogene. Science. 1984 Jun 29;224(4656):1456–1459. doi: 10.1126/science.6328658. [DOI] [PubMed] [Google Scholar]
  74. Demple B., Linn S. DNA N-glycosylases and UV repair. Nature. 1980 Sep 18;287(5779):203–208. doi: 10.1038/287203a0. [DOI] [PubMed] [Google Scholar]
  75. Der C. J., Krontiris T. G., Cooper G. M. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci U S A. 1982 Jun;79(11):3637–3640. doi: 10.1073/pnas.79.11.3637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Deutsch W. A., Linn S. DNA binding activity from cultured human fibrolasts that is specific for partially depurinated DNA and that inserts purines into apurinic sites. Proc Natl Acad Sci U S A. 1979 Jan;76(1):141–144. doi: 10.1073/pnas.76.1.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Diamond L., O'Brien T. G., Baird W. M. Tumor promoters and the mechanism of tumor promotion. Adv Cancer Res. 1980;32:1–74. doi: 10.1016/s0065-230x(08)60360-7. [DOI] [PubMed] [Google Scholar]
  78. Dipple A., Roberts J. J. Excision of 7-bromomethylbenz[a]anthracene--DNA adducts in replicating mammalian cells. Biochemistry. 1977 Apr 5;16(7):1499–1503. doi: 10.1021/bi00626a039. [DOI] [PubMed] [Google Scholar]
  79. Doll R. An epidemiological perspective of the biology of cancer. Cancer Res. 1978 Nov;38(11 Pt 1):3573–3583. [PubMed] [Google Scholar]
  80. Doll R., Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981 Jun;66(6):1191–1308. [PubMed] [Google Scholar]
  81. Doll R., Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981 Jun;66(6):1191–1308. [PubMed] [Google Scholar]
  82. Doll R. Strategy for detection of cancer hazards to man. Nature. 1977 Feb 17;265(5595):589–596. doi: 10.1038/265589a0. [DOI] [PubMed] [Google Scholar]
  83. Doll R. The epidemiology of cancer. Cancer. 1980 May 15;45(10):2475–2485. doi: 10.1002/1097-0142(19800515)45:10<2475::aid-cncr2820451004>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  84. Doolittle R. F., Hunkapiller M. W., Hood L. E., Devare S. G., Robbins K. C., Aaronson S. A., Antoniades H. N. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science. 1983 Jul 15;221(4607):275–277. doi: 10.1126/science.6304883. [DOI] [PubMed] [Google Scholar]
  85. Downward J., Yarden Y., Mayes E., Scrace G., Totty N., Stockwell P., Ullrich A., Schlessinger J., Waterfield M. D. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature. 1984 Feb 9;307(5951):521–527. doi: 10.1038/307521a0. [DOI] [PubMed] [Google Scholar]
  86. Drake J. W., Baltz R. H. The biochemistry of mutagenesis. Annu Rev Biochem. 1976;45:11–37. doi: 10.1146/annurev.bi.45.070176.000303. [DOI] [PubMed] [Google Scholar]
  87. Dube D. K., Loeb L. A. Manganese as a mutagenic agent during in vitro DNA synthesis. Biochem Biophys Res Commun. 1975 Dec 1;67(3):1041–1046. doi: 10.1016/0006-291x(75)90779-2. [DOI] [PubMed] [Google Scholar]
  88. Dunphy W. G., Delclos K. B., Blumberg P. M. Characterization of specific binding of [3H]phorbol 12,13-dibutyrate and [3H]phorbol 12-myristate 13-acetate to mouse brain. Cancer Res. 1980 Oct;40(10):3635–3641. [PubMed] [Google Scholar]
  89. Eastman A., Mossman B. T., Bresnick E. Formation and removal of benzo(a)pyrene adducts of DNA in hamster tracheal epithelial cells. Cancer Res. 1981 Jul;41(7):2605–2610. [PubMed] [Google Scholar]
  90. Eisenstadt E., Warren A. J., Porter J., Atkins D., Miller J. H. Carcinogenic epoxides of benzo[a]pyrene and cyclopenta[cd]pyrene induce base substitutions via specific transversions. Proc Natl Acad Sci U S A. 1982 Mar;79(6):1945–1949. doi: 10.1073/pnas.79.6.1945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Ellis R. W., DeFeo D., Maryak J. M., Young H. A., Shih T. Y., Chang E. H., Lowy D. R., Scolnick E. M. Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus. J Virol. 1980 Nov;36(2):408–420. doi: 10.1128/jvi.36.2.408-420.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Embleton M. J., Middle J. G. Immune responses to naturally occurring rat sarcomas. Br J Cancer. 1981 Jan;43(1):44–52. doi: 10.1038/bjc.1981.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Farber E., Cameron R. The sequential analysis of cancer development. Adv Cancer Res. 1980;31:125–226. doi: 10.1016/s0065-230x(08)60658-2. [DOI] [PubMed] [Google Scholar]
  94. Farber E. Chemical carcinogenesis. N Engl J Med. 1981 Dec 3;305(23):1379–1389. doi: 10.1056/NEJM198112033052304. [DOI] [PubMed] [Google Scholar]
  95. Farber E. Chemical carcinogenesis: a current biological perspective. Carcinogenesis. 1984 Jan;5(1):1–5. doi: 10.1093/carcin/5.1.1. [DOI] [PubMed] [Google Scholar]
  96. Farrar W. L., Elgert K. D. Suppressor cell activity in tumor-bearing mice. II. Inhibition of DNA synthesis and DNA polymerases by TBH splenic suppressor cells. J Immunol. 1978 Apr;120(4):1354–1361. [PubMed] [Google Scholar]
  97. Fears T. R., Douglas J. F. Suggested procedures for reducing the pathology workload in a carcinogen bioassay program, Part I. J Environ Pathol Toxicol. 1978 Sep-Oct;1(1):125–137. [PubMed] [Google Scholar]
  98. Fears T. R., Tarone R. E., Chu K. C. False-positive and false-negative rates for carcinogenicity screens. Cancer Res. 1977 Jul;37(7 Pt 1):1941–1945. [PubMed] [Google Scholar]
  99. Feldman G., Remsen J., Shinohara K., Cerutti P. Excisability and persistence of benzo(a)pyrene DNA adducts in epithelioid human lung cells. Nature. 1978 Aug 24;274(5673):796–798. doi: 10.1038/274796a0. [DOI] [PubMed] [Google Scholar]
  100. Fidler I. J., Gersten D. M., Hart I. R. The biology of cancer invasion and metastasis. Adv Cancer Res. 1978;28:149–250. doi: 10.1016/s0065-230x(08)60648-x. [DOI] [PubMed] [Google Scholar]
  101. Fidler I. J., Gersten D. M., Kripke M. L. Influence of immune status on the metastasis of three murine fibrosarcomas of different immunogenicities. Cancer Res. 1979 Oct;39(10):3816–3821. [PubMed] [Google Scholar]
  102. Forbes P. D., Davies R. E., Urbach F. Aging, environmental influences, and photocarcinogenesis. J Invest Dermatol. 1979 Jul;73(1):131–134. doi: 10.1111/1523-1747.ep12532802. [DOI] [PubMed] [Google Scholar]
  103. Fornace A. J., Jr Recombination of parent and daughter strand DNA after UV-irradiation in mammalian cells. Nature. 1983 Aug 11;304(5926):552–554. doi: 10.1038/304552a0. [DOI] [PubMed] [Google Scholar]
  104. Foucar K., McKenna R. W., Bloomfield C. D., Bowers T. K., Brunning R. D. Therapy-related leukemia: a panmyelosis. Cancer. 1979 Apr;43(4):1285–1296. doi: 10.1002/1097-0142(197904)43:4<1285::aid-cncr2820430416>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  105. Franchini G., Gelmann E. P., Dalla-Favera R., Gallo R. C., Wong-Staal F. Human gene (c-fes) related to the onc sequences of Snyder-Theilen feline sarcoma virus. Mol Cell Biol. 1982 Aug;2(8):1014–1019. doi: 10.1128/mcb.2.8.1014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Fraumeni J. F., Jr Epidemiologic approaches to cancer etiology. Annu Rev Public Health. 1982;3:85–100. doi: 10.1146/annurev.pu.03.050182.000505. [DOI] [PubMed] [Google Scholar]
  107. Friedberg E. C., Bonura T., Love J. D., McMillan S., Radany E. H., Schultz R. A. The repair of DNA damage: recent developments and new insights. J Supramol Struct Cell Biochem. 1981;16(1):91–103. doi: 10.1002/jsscb.1981.380160109. [DOI] [PubMed] [Google Scholar]
  108. Fujiwara Y., Tatsumi M. Replicative bypass repair of ultraviolet damage to DNA of mammalian cells: caffeine sensitive and caffeine resistant mechanisms. Mutat Res. 1976 Oct;37(1):91–110. doi: 10.1016/0027-5107(76)90058-0. [DOI] [PubMed] [Google Scholar]
  109. Gabridge M. G., Legator M. S. A host-mediated microbial assay for the detection of mutagenic compounds. Proc Soc Exp Biol Med. 1969 Mar;130(3):831–834. doi: 10.3181/00379727-130-33666. [DOI] [PubMed] [Google Scholar]
  110. Gallo R. C., Wong-Staal F. Current thoughts on the viral etiology of certain human cancers: The Richard and Hinda Rosenthal Foundation Award lecture. Cancer Res. 1984 Jul;44(7):2743–2749. [PubMed] [Google Scholar]
  111. Gart J. J., Chu K. C., Tarone R. E. Statistical issues in interpretation of chronic bioassay tests for carcinogenicity. J Natl Cancer Inst. 1979 Apr;62(4):957–974. [PubMed] [Google Scholar]
  112. Gaylor D. W., Kodell R. L. Linear interpolation algorithm for low dose risk assessment of toxic substances. J Environ Pathol Toxicol. 1980 Nov;4(5-6):305–312. [PubMed] [Google Scholar]
  113. Gehring P. J., Blau G. E. Mechanisms of carcinogenesis: dose response. J Environ Pathol Toxicol. 1978 Sep-Oct;1(1):163–179. [PubMed] [Google Scholar]
  114. Gehring P. J., Watanabe P. G., Park C. N. Resolution of dose-response toxicity data for chemicals requiring metabolic activation: example--vinyl chloride. Toxicol Appl Pharmacol. 1978 Jun;44(3):581–591. doi: 10.1016/0041-008x(78)90266-1. [DOI] [PubMed] [Google Scholar]
  115. Gelboin H. V. Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev. 1980 Oct;60(4):1107–1166. doi: 10.1152/physrev.1980.60.4.1107. [DOI] [PubMed] [Google Scholar]
  116. Generoso W. M., Bishop J. B., Gosslee D. G., Newell G. W., Sheu C. J., von Halle E. Heritable translocation test in mice. Mutat Res. 1980 Sep;76(2):191–215. doi: 10.1016/0165-1110(80)90010-x. [DOI] [PubMed] [Google Scholar]
  117. Gerchman L. L., Ludlum D. B. The properties of O 6 -methylguanine in templates for RNA polymerase. Biochim Biophys Acta. 1973 May 10;308(2):310–316. doi: 10.1016/0005-2787(73)90160-3. [DOI] [PubMed] [Google Scholar]
  118. Gile J. D., Gillett J. W. Fate of 14C dieldrin in a simulated terrestrial ecosystem. Arch Environ Contam Toxicol. 1979;8(1):107–124. doi: 10.1007/BF01055145. [DOI] [PubMed] [Google Scholar]
  119. Gile J. D., Gillett J. W. Fate of selected fungicides in a terrestrial laboratory ecosystem. J Agric Food Chem. 1979 Nov-Dec;27(6):1159–1164. doi: 10.1021/jf60226a016. [DOI] [PubMed] [Google Scholar]
  120. Gile J. D., Gillett J. W. Transport and fate of organophosphate insecticides in a laboratory model ecosystem. J Agric Food Chem. 1981 May-Jun;29(3):616–621. doi: 10.1021/jf00105a044. [DOI] [PubMed] [Google Scholar]
  121. Gimbrone M. A., Jr, Cotran R. S., Leapman S. B., Folkman J. Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst. 1974 Feb;52(2):413–427. doi: 10.1093/jnci/52.2.413. [DOI] [PubMed] [Google Scholar]
  122. Gisser S. D. Papovavirus and squamous cell carcinoma. Hum Pathol. 1981 Feb;12(2):190–193. doi: 10.1016/s0046-8177(81)80108-6. [DOI] [PubMed] [Google Scholar]
  123. Goldfarb M., Shimizu K., Perucho M., Wigler M. Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature. 1982 Apr 1;296(5856):404–409. doi: 10.1038/296404a0. [DOI] [PubMed] [Google Scholar]
  124. Goldman P. Biochemical pharmacology of the intestinal flora. Annu Rev Pharmacol Toxicol. 1978;18:523–539. doi: 10.1146/annurev.pa.18.040178.002515. [DOI] [PubMed] [Google Scholar]
  125. Goldstein B. D., Witz G., Amoruso M., Stone D. S., Troll W. Stimulation of human polymorphonuclear leukocyte superoxide anion radical production by tumor promoters. Cancer Lett. 1981 Jan;11(3):257–262. doi: 10.1016/0304-3835(81)90117-8. [DOI] [PubMed] [Google Scholar]
  126. Goldwater L. J., Rosso A. J., Kleinfeld M. Bladder tumors in a coal tar dye plant. Arch Environ Health. 1965 Dec;11(6):814–817. doi: 10.1080/00039896.1965.10664306. [DOI] [PubMed] [Google Scholar]
  127. Gombar C. T., Katz E. J., Magee P. N., Sirover M. A. Induction of the DNA repair enzymes uracil DNA glycosylase and 3-methyladenine DNA glycosylase in regenerating rat liver. Carcinogenesis. 1981;2(7):595–599. doi: 10.1093/carcin/2.7.595. [DOI] [PubMed] [Google Scholar]
  128. Gonda T. J., Metcalf D. Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature. 1984 Jul 19;310(5974):249–251. doi: 10.1038/310249a0. [DOI] [PubMed] [Google Scholar]
  129. Goth R., Rajewsky M. F. Persistence of O6-ethylguanine in rat-brain DNA: correlation with nervous system-specific carcinogenesis by ethylnitrosourea. Proc Natl Acad Sci U S A. 1974 Mar;71(3):639–643. doi: 10.1073/pnas.71.3.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Grant W. F. Chromosome aberration assays in Allium. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res. 1982 Nov;99(3):273–291. doi: 10.1016/0165-1110(82)90046-x. [DOI] [PubMed] [Google Scholar]
  131. Greenberger J. S., Newburger P. E., Karpas A., Moloney W. C. Constitutive and inducible granulocyte-macrophage functions in mouse, rat, and human myeloid leukemia-derived continuous tissue culture lines. Cancer Res. 1978 Oct;38(10):3340–3348. [PubMed] [Google Scholar]
  132. Griesemer R. A., Cueto C., Jr Toward a classification scheme for degrees of experimental evidence for the carcinogenicity of chemicals for animals. IARC Sci Publ. 1980;(27):259–281. [PubMed] [Google Scholar]
  133. Grossman L. Enzymes involved in the repair of damaged DNA. Arch Biochem Biophys. 1981 Oct 15;211(2):511–522. doi: 10.1016/0003-9861(81)90485-9. [DOI] [PubMed] [Google Scholar]
  134. Grunberger D., Weinstein I. B. Biochemical effects of the modification of nucleic acids by certain polycyclic aromatic carcinogens. Prog Nucleic Acid Res Mol Biol. 1979;23:105–149. doi: 10.1016/s0079-6603(08)60132-4. [DOI] [PubMed] [Google Scholar]
  135. Guernsey D. L., Ong A., Borek C. Thyroid hormone modulation of X ray-induced in vitro neoplastic transformation. Nature. 1980 Dec 11;288(5791):591–592. doi: 10.1038/288591a0. [DOI] [PubMed] [Google Scholar]
  136. Hadley W. M., Dahl A. R. Cytochrome P-450-dependent monooxygenase activity in nasal membranes of six species. Drug Metab Dispos. 1983 May-Jun;11(3):275–276. [PubMed] [Google Scholar]
  137. Hankin J. H., Rawlings V. Diet and breast cancer: a review. Am J Clin Nutr. 1978 Nov;31(11):2005–2016. doi: 10.1093/ajcn/31.11.2005. [DOI] [PubMed] [Google Scholar]
  138. Harnden D. G., Taylor A. M. Chromosomes and neoplasia. Adv Hum Genet. 1979;9:1-70, 355-60. doi: 10.1007/978-1-4615-8276-2_1. [DOI] [PubMed] [Google Scholar]
  139. Hart I. R., Fidler I. J. Cancer invasion and metastasis. Q Rev Biol. 1980 Jun;55(2):121–142. doi: 10.1086/411730. [DOI] [PubMed] [Google Scholar]
  140. Hart R. W., Hall K. Y., Daniel F. B. DNA repair and mutagenesis in mammalian cells. Photochem Photobiol. 1978 Aug;28(2):131–155. doi: 10.1111/j.1751-1097.1978.tb07689.x. [DOI] [PubMed] [Google Scholar]
  141. Hart R. W., Setlow R. B. Correlation between deoxyribonucleic acid excision-repair and life-span in a number of mammalian species. Proc Natl Acad Sci U S A. 1974 Jun;71(6):2169–2173. doi: 10.1073/pnas.71.6.2169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Hart R. W., Setlow R. B., Woodhead A. D. Evidence that pyrimidine dimers in DNA can give rise to tumors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5574–5578. doi: 10.1073/pnas.74.12.5574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Hart R. W., Turturro A. Evolution and longevity-assurance processes. Naturwissenschaften. 1981 Nov;68(11):552–557. doi: 10.1007/BF00401663. [DOI] [PubMed] [Google Scholar]
  144. Hartley H. O., Sielken R. L., Jr Estimation of "safe doses" in carcinogenic experiments. Biometrics. 1977 Mar;33(1):1–30. [PubMed] [Google Scholar]
  145. Haseman J. K. A reexamination of false-positive rates for carcinogenesis studies. Fundam Appl Toxicol. 1983 Jul-Aug;3(4):334–339. doi: 10.1016/s0272-0590(83)80148-1. [DOI] [PubMed] [Google Scholar]
  146. Haseman J. K., Hoel D. G., Jennrich R. I. Some practical problems arising from use of the gamma multihit model for risk estimation. J Toxicol Environ Health. 1981 Sep;8(3):379–386. doi: 10.1080/15287398109530076. [DOI] [PubMed] [Google Scholar]
  147. Hayday A. C., Gillies S. D., Saito H., Wood C., Wiman K., Hayward W. S., Tonegawa S. Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus. 1984 Jan 26-Feb 1Nature. 307(5949):334–340. doi: 10.1038/307334a0. [DOI] [PubMed] [Google Scholar]
  148. Hayward W. S., Neel B. G., Astrin S. M. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature. 1981 Apr 9;290(5806):475–480. doi: 10.1038/290475a0. [DOI] [PubMed] [Google Scholar]
  149. Heddle J. A., Hite M., Kirkhart B., Mavournin K., MacGregor J. T., Newell G. W., Salamone M. F. The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res. 1983 Sep;123(1):61–118. doi: 10.1016/0165-1110(83)90047-7. [DOI] [PubMed] [Google Scholar]
  150. Heidelberger C. Chemical carcinogenesis. Annu Rev Biochem. 1975;44:79–121. doi: 10.1146/annurev.bi.44.070175.000455. [DOI] [PubMed] [Google Scholar]
  151. Heidelberger C., Freeman A. E., Pienta R. J., Sivak A., Bertram J. S., Casto B. C., Dunkel V. C., Francis M. W., Kakunaga T., Little J. B. Cell transformation by chemical agents--a review and analysis of the literature. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res. 1983 Apr;114(3):283–385. doi: 10.1016/0165-1110(83)90036-2. [DOI] [PubMed] [Google Scholar]
  152. Heinze J. E., Poulsen N. K. The optimal design of batteries of short-term tests for detecting carcinogens. Mutat Res. 1983 May-Jun;117(3-4):259–269. doi: 10.1016/0165-1218(83)90126-x. [DOI] [PubMed] [Google Scholar]
  153. Heppner G. H. Tumor heterogeneity. Cancer Res. 1984 Jun;44(6):2259–2265. [PubMed] [Google Scholar]
  154. Herlyn M., Steplewski Z., Herlyn D., Koprowski H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1438–1442. doi: 10.1073/pnas.76.3.1438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Hewitt H. B. The choice of animal tumors for experimental studies of cancer therapy. Adv Cancer Res. 1978;27:149–200. doi: 10.1016/s0065-230x(08)60932-x. [DOI] [PubMed] [Google Scholar]
  156. Hicks R. M. Effect of promoters on incidence of bladder cancer in experimental animal models. Environ Health Perspect. 1983 Apr;50:37–49. doi: 10.1289/ehp.835037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Higgins N. P., Kato K., Strauss B. A model for replication repair in mammalian cells. J Mol Biol. 1976 Mar 5;101(3):417–425. doi: 10.1016/0022-2836(76)90156-x. [DOI] [PubMed] [Google Scholar]
  158. Higginson J. Cancer and environment: Higginson speaks out. Science. 1979 Sep 28;205(4413):1363-4, 1366. doi: 10.1126/science.472753. [DOI] [PubMed] [Google Scholar]
  159. Hoel D. G., Gaylor D. W., Kirschstein R. L., Saffiotti U., Schneiderman M. A. Estimation of risks of irreversible, delayed toxicity. J Toxicol Environ Health. 1975 Sep;1(1):133–151. doi: 10.1080/15287397509529314. [DOI] [PubMed] [Google Scholar]
  160. Hoel D. G. Incorporation of background in dose-response models. Fed Proc. 1980 Jan;39(1):73–75. [PubMed] [Google Scholar]
  161. Hoel D. G., Kaplan N. L., Anderson M. W. Implication of nonlinear kinetics on risk estimation in carcinogenesis. Science. 1983 Mar 4;219(4588):1032–1037. doi: 10.1126/science.6823565. [DOI] [PubMed] [Google Scholar]
  162. Hoel D. G. Statistical measures of risk. Drug Metab Rev. 1982;13(5):829–838. doi: 10.3109/03602538208991363. [DOI] [PubMed] [Google Scholar]
  163. Hollstein M., McCann J., Angelosanto F. A., Nichols W. W. Short-term tests for carcinogens and mutagens. Mutat Res. 1979 Sep;65(3):133–226. doi: 10.1016/0165-1110(79)90014-9. [DOI] [PubMed] [Google Scholar]
  164. Hopper K. E., Harrison J., Nelson D. S. Partial characterization of anti-tumor effector macrophages in the peritoneal cavities of concomitantly immune mice and mice injected with macrophage-stimulating agents. J Reticuloendothel Soc. 1979 Sep;26(3):259–271. [PubMed] [Google Scholar]
  165. Hsie A. W., Casciano D. A., Couch D. B., Krahn D. F., O'Neill J. P., Whitfield B. L. The use of Chinese hamster ovary cells to quantify specific locus mutation and to determine mutagenicity of chemicals. A report of the gene-tox program. Mutat Res. 1981 Mar;86(2):193–214. doi: 10.1016/0165-1110(81)90024-5. [DOI] [PubMed] [Google Scholar]
  166. Huberman E., Sachs L. Cell-mediated mutagenesis of mammalian cells with chemical carcinogens. Int J Cancer. 1974 Mar 15;13(3):326–333. doi: 10.1002/ijc.2910130308. [DOI] [PubMed] [Google Scholar]
  167. Huff J. Carcinogenesis bioassay results from the National Toxicology Program. Environ Health Perspect. 1982 Nov;45:185–198. doi: 10.1289/ehp.8245185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Ikenaga M., Ishii Y., Tada M., Kakunaga T., Takebe H. Excision-repair of 4-nitroquinolin-1-oxide damage responsible for killing, mutation, and cancer. Basic Life Sci. 1975;5B:763–771. doi: 10.1007/978-1-4684-2898-8_54. [DOI] [PubMed] [Google Scholar]
  169. Jacobs S., Sahyoun N. E., Saltiel A. R., Cuatrecasas P. Phorbol esters stimulate the phosphorylation of receptors for insulin and somatomedin C. Proc Natl Acad Sci U S A. 1983 Oct;80(20):6211–6213. doi: 10.1073/pnas.80.20.6211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Janss D. H., Ben T. L. Age-related modification of 7,12-dimethylbenz[a]anthracene binding to rat mammary gland DNA. J Natl Cancer Inst. 1978 Jan;60(1):173–177. doi: 10.1093/jnci/60.1.173. [DOI] [PubMed] [Google Scholar]
  171. Jennette K. W. The role of metals in carcinogenesis: biochemistry and metabolism. Environ Health Perspect. 1981 Aug;40:233–252. doi: 10.1289/ehp.8140233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Kalyanaraman V. S., Sarngadharan M. G., Nakao Y., Ito Y., Aoki T., Gallo R. C. Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc Natl Acad Sci U S A. 1982 Mar;79(5):1653–1657. doi: 10.1073/pnas.79.5.1653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Kandaswami C., O'Brien P. J. Effects of asbestos on membrane transport and metabolism of benzo(a)pyrene. Biochem Biophys Res Commun. 1980 Nov 28;97(2):794–801. doi: 10.1016/0006-291x(80)90334-4. [DOI] [PubMed] [Google Scholar]
  174. Karin M., Haslinger A., Holtgreve H., Richards R. I., Krauter P., Westphal H. M., Beato M. Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature. 1984 Apr 5;308(5959):513–519. doi: 10.1038/308513a0. [DOI] [PubMed] [Google Scholar]
  175. Karran P., Lindahl T. Hypoxanthine in deoxyribonucleic acid: generation by heat-induced hydrolysis of adenine residues and release in free form by a deoxyribonucleic acid glycosylase from calf thymus. Biochemistry. 1980 Dec 23;19(26):6005–6011. doi: 10.1021/bi00567a010. [DOI] [PubMed] [Google Scholar]
  176. Karran P., Lindahl T., Ofsteng I., Evensen G. B., Seeberg E. Escherichia coli mutants deficient in 3-methyladenine-DNA glycosylase. J Mol Biol. 1980 Jun 15;140(1):101–127. doi: 10.1016/0022-2836(80)90358-7. [DOI] [PubMed] [Google Scholar]
  177. Kelner A. Effect of Visible Light on the Recovery of Streptomyces Griseus Conidia from Ultra-violet Irradiation Injury. Proc Natl Acad Sci U S A. 1949 Feb;35(2):73–79. doi: 10.1073/pnas.35.2.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Ketterer B. INteractions between carcinogens and proteins. Br Med Bull. 1980 Jan;36(1):71–78. doi: 10.1093/oxfordjournals.bmb.a071617. [DOI] [PubMed] [Google Scholar]
  179. Klein G. Immune and non-immune control of neoplastic development: contrasting effects of host and tumor evolution. Cancer. 1980 May 15;45(10):2486–2499. doi: 10.1002/1097-0142(19800515)45:10<2486::aid-cncr2820451005>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  180. Klein G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci U S A. 1979 May;76(5):2442–2446. doi: 10.1073/pnas.76.5.2442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Klein G. The role of gene dosage and genetic transpositions in carcinogenesis. Nature. 1981 Nov 26;294(5839):313–318. doi: 10.1038/294313a0. [DOI] [PubMed] [Google Scholar]
  182. Krewski D., Crump K. S., Farmer J., Gaylor D. W., Howe R., Portier C., Salsburg D., Sielken R. L., Van Ryzin J. A comparison of statistical methods for low dose extrapolation utilizing time-to-tumor data. Fundam Appl Toxicol. 1983 May-Jun;3(3):140–160. doi: 10.1016/s0272-0590(83)80075-x. [DOI] [PubMed] [Google Scholar]
  183. Kripke M. L. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst. 1974 Nov;53(5):1333–1336. doi: 10.1093/jnci/53.5.1333. [DOI] [PubMed] [Google Scholar]
  184. Kripke M. L. Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J Natl Cancer Inst. 1979 Sep;63(3):541–548. doi: 10.1093/jnci/63.3.541. [DOI] [PubMed] [Google Scholar]
  185. Krokan H., Wittwer C. U. Uracil DNa-glycosylase from HeLa cells: general properties, substrate specificity and effect of uracil analogs. Nucleic Acids Res. 1981 Jun 11;9(11):2599–2613. doi: 10.1093/nar/9.11.2599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Krontiris T. G., Cooper G. M. Transforming activity of human tumor DNAs. Proc Natl Acad Sci U S A. 1981 Feb;78(2):1181–1184. doi: 10.1073/pnas.78.2.1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Kröger M., Singer B. Ambiguity and transcriptional errors as a result of methylation of N-1 of purines and N-3 of pyrimidines. Biochemistry. 1979 Aug 7;18(16):3493–3500. doi: 10.1021/bi00583a009. [DOI] [PubMed] [Google Scholar]
  188. Kunkel T. A., Loeb L. A. On the fidelity of DNA replication. Effect of divalent metal ion activators and deoxyrionucleoside triphosphate pools on in vitro mutagenesis. J Biol Chem. 1979 Jul 10;254(13):5718–5725. [PubMed] [Google Scholar]
  189. Kutz F. W., Yobs A. R., Strassman S. C., Viar J. F., Jr Effects of reducing DDT usage on total DDT storage in humans. Pestic Monit J. 1977 Sep;11(2):61–63. [PubMed] [Google Scholar]
  190. Käfer E., Scott B. R., Dorn G. L., Stafford R. Aspergillus nidulans: systems and results of tests for chemical induction of mitotic segregation and mutation. I. Diploid and duplication assay systems. A report of the U.S. EPA Gene-Tox Program. Mutat Res. 1982 Jan;98(1):1–48. doi: 10.1016/0165-1110(82)90002-1. [DOI] [PubMed] [Google Scholar]
  191. LEVIN M. L., HAENSZEL W., CARROLL B. E., GERHARDT P. R., HANDY V. H., INGRAHAM S. C., 2nd Cancer incidence in urban and rurl areas of New York State. J Natl Cancer Inst. 1960 Jun;24:1243–1257. [PubMed] [Google Scholar]
  192. Lachman H. M., Skoultchi A. I. Expression of c-myc changes during differentiation of mouse erythroleukaemia cells. Nature. 1984 Aug 16;310(5978):592–594. doi: 10.1038/310592a0. [DOI] [PubMed] [Google Scholar]
  193. Lakowicz J. R., Englund F., Hidmark A. Particle-enhanced membrane uptake of a polynuclear aromatic hydrocarbon: a possible role in cocarcinogenesis. J Natl Cancer Inst. 1978 Oct;61(4):1155–1159. [PubMed] [Google Scholar]
  194. Lam L. K., Sparnins V. L., Hochalter J. B., Wattenberg L. W. Effects of 2- and 3-tert-butyl-4-hydroxyanisole on glutathione S-transferase and epoxide hydrolase activities and sulfhydryl levels in liver and forestomach of mice. Cancer Res. 1981 Oct;41(10):3940–3943. [PubMed] [Google Scholar]
  195. Land H., Parada L. F., Weinberg R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature. 1983 Aug 18;304(5927):596–602. doi: 10.1038/304596a0. [DOI] [PubMed] [Google Scholar]
  196. Lane M. A., Sainten A., Cooper G. M. Activation of related transforming genes in mouse and human mammary carcinomas. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5185–5189. doi: 10.1073/pnas.78.8.5185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Larsen K. H., Brash D., Cleaver J. E., Hart R. W., Maher V. M., Painter R. B., Sega G. A. DNA repair assays as tests for environmental mutagens. A report of the U.S. EPA Gene-Tox Program. Mutat Res. 1982 May;98(3):287–318. doi: 10.1016/0165-1110(82)90037-9. [DOI] [PubMed] [Google Scholar]
  198. Larsen K. H., Brash D., Cleaver J. E., Hart R. W., Maher V. M., Painter R. B., Sega G. A. DNA repair assays as tests for environmental mutagens. A report of the U.S. EPA Gene-Tox Program. Mutat Res. 1982 May;98(3):287–318. doi: 10.1016/0165-1110(82)90037-9. [DOI] [PubMed] [Google Scholar]
  199. Latt S. A., Allen J., Bloom S. E., Carrano A., Falke E., Kram D., Schneider E., Schreck R., Tice R., Whitfield B. Sister-chromatid exchanges: a report of the GENE-TOX program. Mutat Res. 1981 Jul;87(1):17–62. doi: 10.1016/0165-1110(81)90003-8. [DOI] [PubMed] [Google Scholar]
  200. Latt S. A. Microfluorometric detection of deoxyribonucleic acid replication in human metaphase chromosomes. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3395–3399. doi: 10.1073/pnas.70.12.3395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Laval J., Pierre J., Laval F. Release of 7-methylguanine residues from alkylated DNA by extracts of Micrococcus luteus and Escherichia coli. Proc Natl Acad Sci U S A. 1981 Feb;78(2):852–855. doi: 10.1073/pnas.78.2.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Leclercq G., Heuson J. C. Physiological and pharmacological effects of estrogens in breast cancer. Biochim Biophys Acta. 1979 Dec 19;560(4):427–455. doi: 10.1016/0304-419x(79)90012-x. [DOI] [PubMed] [Google Scholar]
  203. Lee Y. T., Sparks F. C., Eilber F. R., Morton D. L. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer. Cancer. 1975 Mar;35(3):748–755. doi: 10.1002/1097-0142(197503)35:3<748::aid-cncr2820350330>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  204. Legator M. S., Bueding E., Batzinger R., Connor T. H., Eisenstadt E., Farrow M. G., Ficsor G., Hsie A., Seed J., Stafford R. S. An evaluation of the host-mediated assay and body fluid analysis. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res. 1982 May;98(3):319–374. doi: 10.1016/0165-1110(82)90038-0. [DOI] [PubMed] [Google Scholar]
  205. Leifer Z., Kada T., Mandel M., Zeiger E., Stafford R., Rosenkranz H. S. An evaluation of tests using DNA repair-deficient bacteria for predicting genotoxicity and carcinogenicity. A report of the U.S. EPA's Gene-TOX Program. Mutat Res. 1981 Nov;87(3):211–297. doi: 10.1016/0165-1110(81)90015-4. [DOI] [PubMed] [Google Scholar]
  206. Lett J. T., Caldwell I., Dean C. J., Alexander P. Rejoining of x-ray induced breaks in the DNA of leukaemia cells. Nature. 1967 May 20;214(5090):790–792. doi: 10.1038/214790a0. [DOI] [PubMed] [Google Scholar]
  207. Levine A. J. Transformation-associated tumor antigens. Adv Cancer Res. 1982;37:75–109. doi: 10.1016/s0065-230x(08)60882-9. [DOI] [PubMed] [Google Scholar]
  208. Levinson B., Khoury G., Vande Woude G., Gruss P. Activation of SV40 genome by 72-base pair tandem repeats of Moloney sarcoma virus. Nature. 1982 Feb 18;295(5850):568–572. doi: 10.1038/295568a0. [DOI] [PubMed] [Google Scholar]
  209. Lieberman M. W., Dipple A. Removal of bound carcinogen during DNA repair in nondividing human lymphocytes. Cancer Res. 1972 Sep;32(9):1855–1860. [PubMed] [Google Scholar]
  210. Lin J. K., Miller J. A., Miller E. C. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res. 1977 Dec;37(12):4430–4438. [PubMed] [Google Scholar]
  211. Lindahl T. DNA glycosylases, endonucleases for apurinic/apyrimidinic sites, and base excision-repair. Prog Nucleic Acid Res Mol Biol. 1979;22:135–192. doi: 10.1016/s0079-6603(08)60800-4. [DOI] [PubMed] [Google Scholar]
  212. Lindahl T. DNA repair enzymes. Annu Rev Biochem. 1982;51:61–87. doi: 10.1146/annurev.bi.51.070182.000425. [DOI] [PubMed] [Google Scholar]
  213. Lindahl T., Nyberg B. Rate of depurination of native deoxyribonucleic acid. Biochemistry. 1972 Sep 12;11(19):3610–3618. doi: 10.1021/bi00769a018. [DOI] [PubMed] [Google Scholar]
  214. Liotta L. A., Tryggvason K., Garbisa S., Hart I., Foltz C. M., Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980 Mar 6;284(5751):67–68. doi: 10.1038/284067a0. [DOI] [PubMed] [Google Scholar]
  215. Lipetz P. D., Galsky A. G., Stephens R. E. Relationship of DNA tertiary and quaternary structure to carcinogenic processes. Adv Cancer Res. 1982;36:165–210. doi: 10.1016/s0065-230x(08)60425-x. [DOI] [PubMed] [Google Scholar]
  216. Littlefield N. A., Farmer J. H., Gaylor D. W., Sheldon W. G. Effects of dose and time in a long-term, low-dose carcinogenic study. J Environ Pathol Toxicol. 1980;3(3 Spec No):17–34. [PubMed] [Google Scholar]
  217. Littlefield N. A., Greenman D. L., Farmer J. H., Sheldon W. G. Effects of continuous and discontinued exposure to 2-AAF on urinary bladder hyperplasia and neoplasia. J Environ Pathol Toxicol. 1980;3(3 Spec No):35–54. [PubMed] [Google Scholar]
  218. Livneh Z., Elad D., Sperling J. Enzymatic insertion of purine bases into depurinated DNA in vitro. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1089–1093. doi: 10.1073/pnas.76.3.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Lloyd R. S., Hanawalt P. C. Expression of the denV gene of bacteriophage T4 cloned in Escherichia coli. Proc Natl Acad Sci U S A. 1981 May;78(5):2796–2800. doi: 10.1073/pnas.78.5.2796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Loeb L. A., Sirover M. A., Weymouth L. A., Dube D. K., Seal G., Agarwal S. S., Katz E. Infidelity of DNA synthesis as related to mutagenesis and carcinogenesis. J Toxicol Environ Health. 1977 Jul;2(6):1297–1304. doi: 10.1080/15287397709529531. [DOI] [PubMed] [Google Scholar]
  221. Loeb L. A., Weymouth L. A., Kunkel T. A., Gopinathan K. P., Beckman R. A., Dube D. K. On the fidelity of DNA replication. Cold Spring Harb Symp Quant Biol. 1979;43(Pt 2):921–927. doi: 10.1101/sqb.1979.043.01.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Loprieno N., Barale R., Von Halle E. S., von Borstel R. C. Testing of chemicals for mutagenic activity with Schizosaccharomyces pombe. Mutat Res. 1983 Jun;115(2):215–223. doi: 10.1016/0165-1110(83)90004-0. [DOI] [PubMed] [Google Scholar]
  223. Lu A. Y. Multiplicity of liver drug metabolizing enzymes. Drug Metab Rev. 1979;10(2):187–208. doi: 10.3109/03602537908997468. [DOI] [PubMed] [Google Scholar]
  224. Lutz W. K. In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mutat Res. 1979 Dec;65(4):289–356. doi: 10.1016/0165-1110(79)90006-x. [DOI] [PubMed] [Google Scholar]
  225. Lynn R. K., Donielson D. W., Ilias A. M., Kennish J. M., Wong K., Matthews H. B. Metabolism of bisazobiphenyl dyes derived from benzidine, 3,3'-dimethylbenzidine or 3,3'-dimethoxybenzidine to carcinogenic aromatic amines in the dog and rat. Toxicol Appl Pharmacol. 1980 Nov;56(2):248–258. doi: 10.1016/0041-008x(80)90296-3. [DOI] [PubMed] [Google Scholar]
  226. MANTEL N., BRYAN W. R. "Safety" testing of carcinogenic agents. J Natl Cancer Inst. 1961 Aug;27:455–470. [PubMed] [Google Scholar]
  227. Maclure K. M., MacMahon B. An epidemiologic perspective of environmental carcinogenesis. Epidemiol Rev. 1980;2:19–48. doi: 10.1093/oxfordjournals.epirev.a036222. [DOI] [PubMed] [Google Scholar]
  228. Maher V. M., Rowan L. A., Silinskas K. C., Kateley S. A., McCormick J. J. Frequency of UV-induced neoplastic transformation of diploid human fibroblasts is higher in xeroderma pigmentosum cells than in normal cells. Proc Natl Acad Sci U S A. 1982 Apr;79(8):2613–2617. doi: 10.1073/pnas.79.8.2613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. Malling H. V. Dimethylnitrosamine: formation of mutagenic compounds by interaction with mouse liver microsomes. Mutat Res. 1971 Dec;13(4):425–429. doi: 10.1016/0027-5107(71)90054-6. [DOI] [PubMed] [Google Scholar]
  230. Mantel N., Bohidar N. R., Brown C. C., Ciminera J. L., Tukey J. W. An improved Mantel-Bryan procedure for "safety" testing of carcinogens. Cancer Res. 1975 Apr;35(4):865–872. [PubMed] [Google Scholar]
  231. Margison G. P. Chronic or acute administration of various dialkylnitrosamines enhances the removal of O6-methylguanine from rat liver DNA in vivo. Chem Biol Interact. 1982 Jan;38(2):189–201. doi: 10.1016/0009-2797(82)90039-4. [DOI] [PubMed] [Google Scholar]
  232. Margison G. P., Pegg A. E. Enzymatic release of 7-methylguanine from methylated DNA by rodent liver extracts. Proc Natl Acad Sci U S A. 1981 Feb;78(2):861–865. doi: 10.1073/pnas.78.2.861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Margolin B. H., Kaplan N., Zeiger E. Statistical analysis of the Ames Salmonella/microsome test. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3779–3783. doi: 10.1073/pnas.78.6.3779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. Marks F. Epidermal growth control mechanisms, hyperplasia, and tumor promotion in the skin. Cancer Res. 1976 Jul;36(7 Pt 2):2636–2643. [PubMed] [Google Scholar]
  235. Maron D. M., Ames B. N. Revised methods for the Salmonella mutagenicity test. Mutat Res. 1983 May;113(3-4):173–215. doi: 10.1016/0165-1161(83)90010-9. [DOI] [PubMed] [Google Scholar]
  236. Martin C. N., Kennelly J. C. Rat liver microsomal azoreductase activity on four azo dyes derived from benzidine, 3,3'-dimethylbenzidine or 3,3'-dimethoxybenzidine. Carcinogenesis. 1981;2(4):307–312. doi: 10.1093/carcin/2.4.307. [DOI] [PubMed] [Google Scholar]
  237. McCann J., Choi E., Yamasaki E., Ames B. N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5135–5139. doi: 10.1073/pnas.72.12.5135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  238. McDougall J. K., Crum C. P., Fenoglio C. M., Goldstein L. C., Galloway D. A. Herpesvirus-specific RNA and protein in carcinoma of the uterine cervix. Proc Natl Acad Sci U S A. 1982 Jun;79(12):3853–3857. doi: 10.1073/pnas.79.12.3853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  239. McGrath J. P., Capon D. J., Goeddel D. V., Levinson A. D. Comparative biochemical properties of normal and activated human ras p21 protein. Nature. 1984 Aug 23;310(5979):644–649. doi: 10.1038/310644a0. [DOI] [PubMed] [Google Scholar]
  240. McKim J. M., Eaton J. G., Holcombe G. W. Metal toxicity to embryos and larvae of eight species of freshwater fish-II: copper. Bull Environ Contam Toxicol. 1978 May;19(5):608–616. doi: 10.1007/BF01685847. [DOI] [PubMed] [Google Scholar]
  241. Mehta J. R., Ludlum D. B., Renard A., Verly W. G. Repair of O6-ethylguanine in DNA by a chromatin fraction from rat liver: transfer of the ethyl group to an acceptor protein. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6766–6770. doi: 10.1073/pnas.78.11.6766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  242. Mehta J. R., Ludlum D. B. Synthesis and properties of O6-methyldeoxyguanylic acid and its copolymers with deoxycytidylic acid. Biochim Biophys Acta. 1978 Dec 21;521(2):770–778. doi: 10.1016/0005-2787(78)90316-7. [DOI] [PubMed] [Google Scholar]
  243. Mehta R. G., Moon R. C. Inhibition of DNA synthesis by retinyl acetate during chemically induced mammary carcinogenesis. Cancer Res. 1980 Apr;40(4):1109–1111. [PubMed] [Google Scholar]
  244. Melnick R. L., Boorman G. A., Haseman J. K., Montali R. J., Huff J. Urolithiasis and bladder carcinogenicity of melamine in rodents. Toxicol Appl Pharmacol. 1984 Feb;72(2):292–303. doi: 10.1016/0041-008x(84)90314-4. [DOI] [PubMed] [Google Scholar]
  245. Meneghini R., Hanawalt P. T4-endonuclease V-sensitive sites in DNA from ultraviolet-irradiated human cells. Biochim Biophys Acta. 1976 Apr 2;425(4):428–437. doi: 10.1016/0005-2787(76)90007-1. [DOI] [PubMed] [Google Scholar]
  246. Meuth M., L'Heureux-Huard N., Trudel M. Characterization of a mutator gene in Chinese hamster ovary cells. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6505–6509. doi: 10.1073/pnas.76.12.6505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  247. Miao R. M., Filedsteel A. H., Fodge D. W. Opposing effects of tumor promoters on erythroid differentiation. Nature. 1978 Jul 20;274(5668):271–272. doi: 10.1038/274271a0. [DOI] [PubMed] [Google Scholar]
  248. Miller E. C. Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. Cancer Res. 1978 Jun;38(6):1479–1496. [PubMed] [Google Scholar]
  249. Miller J. A. Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. Cancer Res. 1970 Mar;30(3):559–576. [PubMed] [Google Scholar]
  250. Miller R. C., Geard C. R., Osmak R. S., Rutledge-Freeman M., Ong A., Mason H., Napholz A., Perez N., Harisiadis L., Borek C. Modification of sister chromatid exchanges and radiation-induced transformation in rodent cells by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate and two retinoids. Cancer Res. 1981 Feb;41(2):655–659. [PubMed] [Google Scholar]
  251. Mitchell A. D., Casciano D. A., Meltz M. L., Robinson D. E., San R. H., Williams G. M., Von Halle E. S. Unscheduled DNA synthesis tests. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res. 1983 Dec;123(3):363–410. doi: 10.1016/0165-1110(83)90029-5. [DOI] [PubMed] [Google Scholar]
  252. Montesano R., Brésil H., Margison G. P. Increased excision of O6-methylguanine from rat liver DNA after chronic administration of dimethylnitrosamine. Cancer Res. 1979 May;39(5):1798–1802. [PubMed] [Google Scholar]
  253. Morgan R. W., Hoffmann G. R. Cycasin and its mutagenic metabolites. Mutat Res. 1983 Jan;114(1):19–58. doi: 10.1016/0165-1110(83)90018-0. [DOI] [PubMed] [Google Scholar]
  254. Mossman B. T., Craighead J. E., MacPherson B. V. Asbestos-induced epithelial changes in organ cultures of hamster trachea: inhibition by retinyl methyl ether. Science. 1980 Jan 18;207(4428):311–313. doi: 10.1126/science.7350661. [DOI] [PubMed] [Google Scholar]
  255. Mossman B. T., Craighead J. E. Mechanisms of asbestos carcinogenesis. Environ Res. 1981 Aug;25(2):269–280. doi: 10.1016/0013-9351(81)90028-1. [DOI] [PubMed] [Google Scholar]
  256. Mueller G. C., Kajiwara K., Kim U. H., Graham J. Proposed coupling of chromatin replication, hormone action, and cell differentiation. Cancer Res. 1978 Nov;38(11 Pt 2):4041–4045. [PubMed] [Google Scholar]
  257. Munro I. C. Considerations in chronic toxicity testing: the chemical, the dose, the design. J Environ Pathol Toxicol. 1977 Nov-Dec;1(2):183–197. [PubMed] [Google Scholar]
  258. Murad T. M., Contesso G., Mouriesse H. Papillary tumors of large lactiferous ducts. Cancer. 1981 Jul 1;48(1):122–133. doi: 10.1002/1097-0142(19810701)48:1<122::aid-cncr2820480123>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  259. Murasaki G., Zenser T. V., Davis B. B., Cohen S. M. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis. Carcinogenesis. 1984 Jan;5(1):53–55. doi: 10.1093/carcin/5.1.53. [DOI] [PubMed] [Google Scholar]
  260. Murphree A. L., Benedict W. F. Retinoblastoma: clues to human oncogenesis. Science. 1984 Mar 9;223(4640):1028–1033. doi: 10.1126/science.6320372. [DOI] [PubMed] [Google Scholar]
  261. Murray M. J., Shilo B. Z., Shih C., Cowing D., Hsu H. W., Weinberg R. A. Three different human tumor cell lines contain different oncogenes. Cell. 1981 Aug;25(2):355–361. doi: 10.1016/0092-8674(81)90054-4. [DOI] [PubMed] [Google Scholar]
  262. Nagasawa H., Little J. B. Effect of tumor promoters, protease inhibitors, and repair processes on x-ray-induced sister chromatid exchanges in mouse cells. Proc Natl Acad Sci U S A. 1979 Apr;76(4):1943–1947. doi: 10.1073/pnas.76.4.1943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  263. Naharro G., Robbins K. C., Reddy E. P. Gene product of v-fgr onc: hybrid protein containing a portion of actin and a tyrosine-specific protein kinase. Science. 1984 Jan 6;223(4631):63–66. doi: 10.1126/science.6318314. [DOI] [PubMed] [Google Scholar]
  264. Narisawa T., Reddy B. S., Wong C. Q., Weisburger J. H. Effect of vitamin A deficiency on rat colon carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine. Cancer Res. 1976 Apr;36(4):1379–1383. [PubMed] [Google Scholar]
  265. Neidle S. Carcinogens and DNA. Nature. 1980 Jan 10;283(5743):135–135. doi: 10.1038/283135a0. [DOI] [PubMed] [Google Scholar]
  266. Newmark P. Cancer genes--processed genes--jumping genes. Nature. 1982 Apr 1;296(5856):393–394. doi: 10.1038/296393a0. [DOI] [PubMed] [Google Scholar]
  267. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature. 1984 Apr 19;308(5961):693–698. doi: 10.1038/308693a0. [DOI] [PubMed] [Google Scholar]
  268. Nony C. R., Bowman M. C., Cairns T., Lowry L. K., Tolos W. P. Metabolism studies of an azo dye and pigment in the hamster based on analysis of the urine for potentially carcinogenic aromatic amine metabolites. J Anal Toxicol. 1980 May-Jun;4(3):132–140. doi: 10.1093/jat/4.3.132. [DOI] [PubMed] [Google Scholar]
  269. Nordenskjöld M., Jernström B. Induction and repair of DNA strand breaks in cultured human fibroblasts exposed to various phenols and dihydrodiols of benzo[a]pyrene. Chem Biol Interact. 1982 Aug;41(2):155–168. doi: 10.1016/0009-2797(82)90086-2. [DOI] [PubMed] [Google Scholar]
  270. Oleson F. B., Mitchell B. L., Dipple A., Lieberman M. W. Distribution of DNA damage in chromatin and its relation to repair in human cells treated with 7-bromomethylbenz(a) anthracene. Nucleic Acids Res. 1979 Nov 10;7(5):1343–1361. doi: 10.1093/nar/7.5.1343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  271. Open query: theoretical problems in the modified Mantel-Bryan procedure. Biometrics. 1977 Dec;33(4):752–757. [PubMed] [Google Scholar]
  272. Ornstein R. L., Rein R. Molecular models of induced DNA premutational damage and mutational pathways for the carcinogen 4-nitroquinoline 1-oxide and its metabolites. Chem Biol Interact. 1980 Apr;30(1):87–103. doi: 10.1016/0009-2797(80)90117-9. [DOI] [PubMed] [Google Scholar]
  273. Oser B. L., Hall R. L. Criteria employed by the expert panel of FEMA for the GRAS evaluation of flavouring substances. Food Cosmet Toxicol. 1977 Oct;15(5):457–466. doi: 10.1016/s0015-6264(77)80014-x. [DOI] [PubMed] [Google Scholar]
  274. Oskarsson M., McClements W. L., Blair D. G., Maizel J. V., Vande Woude G. F. Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus. Science. 1980 Mar 14;207(4436):1222–1224. doi: 10.1126/science.6243788. [DOI] [PubMed] [Google Scholar]
  275. Owen A. J., Pantazis P., Antoniades H. N. Simian sarcoma virus--transformed cells secrete a mitogen identical to platelet-derived growth factor. Science. 1984 Jul 6;225(4657):54–56. doi: 10.1126/science.6328659. [DOI] [PubMed] [Google Scholar]
  276. Painter R. B. Does ultraviolet light enhance postreplication repair in mammalian cells? Nature. 1978 Sep 21;275(5677):243–245. doi: 10.1038/275243a0. [DOI] [PubMed] [Google Scholar]
  277. Papkoff J., Lai M. H., Hunter T., Verma I. M. Analysis of transforming gene products from Moloney murine sarcoma virus. Cell. 1981 Nov;27(1 Pt 2):109–119. doi: 10.1016/0092-8674(81)90365-2. [DOI] [PubMed] [Google Scholar]
  278. Parada L. F., Tabin C. J., Shih C., Weinberg R. A. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature. 1982 Jun 10;297(5866):474–478. doi: 10.1038/297474a0. [DOI] [PubMed] [Google Scholar]
  279. Payne G. S., Bishop J. M., Varmus H. E. Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas. Nature. 1982 Jan 21;295(5846):209–214. doi: 10.1038/295209a0. [DOI] [PubMed] [Google Scholar]
  280. Pegg A. E., Scicchitano D., Dolan M. E. Comparison of the rates of repair of O6-alkylguanines in DNA by rat liver and bacterial O6-alkylguanine-DNA alkyltransferase. Cancer Res. 1984 Sep;44(9):3806–3811. [PubMed] [Google Scholar]
  281. Peraino C., Fry R. J., Staffeldt E. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res. 1971 Oct;31(10):1506–1512. [PubMed] [Google Scholar]
  282. Perera F. P. The genotoxic/epigenetic distinction: relevance to cancer policy. Environ Res. 1984 Jun;34(1):175–191. doi: 10.1016/0013-9351(84)90087-2. [DOI] [PubMed] [Google Scholar]
  283. Perera F. P., Weinstein I. B. Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J Chronic Dis. 1982;35(7):581–600. doi: 10.1016/0021-9681(82)90078-9. [DOI] [PubMed] [Google Scholar]
  284. Perucho M., Goldfarb M., Shimizu K., Lama C., Fogh J., Wigler M. Human-tumor-derived cell lines contain common and different transforming genes. Cell. 1981 Dec;27(3 Pt 2):467–476. doi: 10.1016/0092-8674(81)90388-3. [DOI] [PubMed] [Google Scholar]
  285. Peterson A. R., Landolph J. R., Peterson H., Heidelberger C. Mutagenesis of Chinese hamster cells is facilitated by thymidine and deoxycytidine. Nature. 1978 Nov 30;276(5687):508–510. doi: 10.1038/276508a0. [DOI] [PubMed] [Google Scholar]
  286. Peto R., Pike M. C., Day N. E., Gray R. G., Lee P. N., Parish S., Peto J., Richards S., Wahrendorf J. Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monogr Eval Carcinog Risk Chem Hum Suppl. 1980;(2 Suppl):311–426. [PubMed] [Google Scholar]
  287. Pitot H. C., Barsness L., Goldsworthy T., Kitagawa T. Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine. Nature. 1978 Feb 2;271(5644):456–458. doi: 10.1038/271456a0. [DOI] [PubMed] [Google Scholar]
  288. Plewa M. J. Specific-locus mutation assays in Zea mays. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res. 1982 Nov;99(3):317–337. doi: 10.1016/0165-1110(82)90049-5. [DOI] [PubMed] [Google Scholar]
  289. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415–7419. doi: 10.1073/pnas.77.12.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  290. Poiesz B. J., Ruscetti F. W., Reitz M. S., Kalyanaraman V. S., Gallo R. C. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia. Nature. 1981 Nov 19;294(5838):268–271. doi: 10.1038/294268a0. [DOI] [PubMed] [Google Scholar]
  291. Poirier L. A., de Serres F. J. Initial National Cancer Institute studies on mutagenesis as a prescreen for chemical carcinogens: an appraisal. J Natl Cancer Inst. 1979 Apr;62(4):919–926. [PubMed] [Google Scholar]
  292. Poirier M. C. Antibodies to carcinogen-DNA adducts. J Natl Cancer Inst. 1981 Sep;67(3):515–519. [PubMed] [Google Scholar]
  293. Poland A., Glover E. 2,3,7,8,-Tetrachlorodibenzo-p-dioxin: segregation of toxocity with the Ah locus. Mol Pharmacol. 1980 Jan;17(1):86–94. [PubMed] [Google Scholar]
  294. Poole A. R., Tiltman K. J., Recklies A. D., Stoker T. A. Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature. 1978 Jun 15;273(5663):545–547. doi: 10.1038/273545a0. [DOI] [PubMed] [Google Scholar]
  295. Poste G., Nicolson G. L. Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci U S A. 1980 Jan;77(1):399–403. doi: 10.1073/pnas.77.1.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  296. Prakash K., McBride O. W., Swan D. C., Devare S. G., Tronick S. R., Aaronson S. A. Molecular cloning and chromosomal mapping of a human locus related to the transforming gene of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A. 1982 Sep;79(17):5210–5214. doi: 10.1073/pnas.79.17.5210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  297. Preston R. J., Au W., Bender M. A., Brewen J. G., Carrano A. V., Heddle J. A., McFee A. F., Wolff S., Wassom J. S. Mammalian in vivo and in vitro cytogenetic assays: a report of the U.S. EPA's gene-tox program. Mutat Res. 1981 Sep;87(2):143–188. doi: 10.1016/0165-1110(81)90030-0. [DOI] [PubMed] [Google Scholar]
  298. Pulciani S., Santos E., Lauver A. V., Long L. K., Robbins K. C., Barbacid M. Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells. Proc Natl Acad Sci U S A. 1982 May;79(9):2845–2849. doi: 10.1073/pnas.79.9.2845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  299. Purchase I. F. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/6. An appraisal of predictive tests for carcinogenicity. Mutat Res. 1982 Jul;99(1):53–17. doi: 10.1016/0165-1110(82)90031-8. [DOI] [PubMed] [Google Scholar]
  300. Purchase I. F. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/6. An appraisal of predictive tests for carcinogenicity. Mutat Res. 1982 Jul;99(1):53–17. doi: 10.1016/0165-1110(82)90031-8. [DOI] [PubMed] [Google Scholar]
  301. Purchase I. F. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/6. An appraisal of predictive tests for carcinogenicity. Mutat Res. 1982 Jul;99(1):53–17. doi: 10.1016/0165-1110(82)90031-8. [DOI] [PubMed] [Google Scholar]
  302. Purchase I. F., Longstaff E., Ashby J., Styles J. A., Anderson D., Lefevre P. A., Westwood F. R. An evaluation of 6 short-term tests for detecting organic chemical carcinogens. Br J Cancer. 1978 Jun;37(6):873–903. doi: 10.1038/bjc.1978.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  303. Purtilo D. T. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model. Adv Cancer Res. 1981;34:279–312. doi: 10.1016/s0065-230x(08)60244-4. [DOI] [PubMed] [Google Scholar]
  304. Radman M., Kinsella A. R. Chromosomal events in carcinogenic initiation and promotion: implications for carcinogenicity testing and cancer prevention strategies. IARC Sci Publ. 1980;(27):75–90. [PubMed] [Google Scholar]
  305. Radomski J. L. The primary aromatic amines: their biological properties and structure-activity relationships. Annu Rev Pharmacol Toxicol. 1979;19:129–157. doi: 10.1146/annurev.pa.19.040179.001021. [DOI] [PubMed] [Google Scholar]
  306. Rai K., Van Ryzin J. A generalized multihit dose-response model for low-dose extrapolation. Biometrics. 1981 Jun;37(2):341–352. [PubMed] [Google Scholar]
  307. Randerath K., Reddy M. V., Gupta R. C. 32P-labeling test for DNA damage. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6126–6129. doi: 10.1073/pnas.78.10.6126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  308. Ratner L., Nordlund J. J., Lengyel P. Interferon as an inhibitor of cell growth: studies with mouse melanoma cells. Proc Soc Exp Biol Med. 1980 Feb;163(2):267–272. doi: 10.3181/00379727-163-40760. [DOI] [PubMed] [Google Scholar]
  309. Razin A., Friedman J. DNA methylation and its possible biological roles. Prog Nucleic Acid Res Mol Biol. 1981;25:33–52. doi: 10.1016/s0079-6603(08)60482-1. [DOI] [PubMed] [Google Scholar]
  310. Reddy E. P., Reynolds R. K., Santos E., Barbacid M. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature. 1982 Nov 11;300(5888):149–152. doi: 10.1038/300149a0. [DOI] [PubMed] [Google Scholar]
  311. Regan J. D., Trosko J. E., Carrier W. L. Evidence for excision of ultraviolet-induced pyrimidine dimers from the DNA of human cells in vitro. Biophys J. 1968 Mar;8(3):319–325. doi: 10.1016/S0006-3495(68)86490-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  312. Reif A. E. Synergism in carcinogenesis. J Natl Cancer Inst. 1984 Jul;73(1):25–39. [PubMed] [Google Scholar]
  313. Rinkus S. J., Legator M. S. Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system. Cancer Res. 1979 Sep;39(9):3289–3318. [PubMed] [Google Scholar]
  314. Robert-Guroff M., Nakao Y., Notake K., Ito Y., Sliski A., Gallo R. C. Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult T cell leukemia. Science. 1982 Feb 19;215(4535):975–978. doi: 10.1126/science.6760397. [DOI] [PubMed] [Google Scholar]
  315. Roberts J. J. Cellular responses to carcinogen-induced DNA damage and the role of DNA repair. Br Med Bull. 1980 Jan;36(1):25–31. doi: 10.1093/oxfordjournals.bmb.a071609. [DOI] [PubMed] [Google Scholar]
  316. Rovera G., O'Brien T. G., Diamond L. Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture. Proc Natl Acad Sci U S A. 1977 Jul;74(7):2894–2898. doi: 10.1073/pnas.74.7.2894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  317. Rowley J. D. Human oncogene locations and chromosome aberrations. Nature. 1983 Jan 27;301(5898):290–291. doi: 10.1038/301290a0. [DOI] [PubMed] [Google Scholar]
  318. Russell L. B., Selby P. B., von Halle E., Sheridan W., Valcovic L. The mouse specific-locus test with agents other than radiations: interpretation of data and recommendations for future work. Mutat Res. 1981 May;86(3):329–354. doi: 10.1016/0165-1110(81)90010-5. [DOI] [PubMed] [Google Scholar]
  319. Russell L. B., Selby P. B., von Halle E., Sheridan W., Valcovic L. Use of the mouse spot test in chemical mutagenesis: interpretation of past data and recommendations for future work. Mutat Res. 1981 May;86(3):355–379. doi: 10.1016/0165-1110(81)90011-7. [DOI] [PubMed] [Google Scholar]
  320. Rédei G. P. Mutagen assay with Arabidopsis. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res. 1982 Sep;99(2):243–255. [PubMed] [Google Scholar]
  321. Sacher G. A., Hart R. W. Longevity, aging and comparative cellular and molecular biology of the house mouse, Mus musculus, and the white-footed mouse, Peromyscus leucopus. Birth Defects Orig Artic Ser. 1978;14(1):71–96. [PubMed] [Google Scholar]
  322. Saedler H., Starlinger P. 0 degree mutations in the galactose operon in E. coli. I. Genetic characterization. Mol Gen Genet. 1967;100(2):178–189. doi: 10.1007/BF00333604. [DOI] [PubMed] [Google Scholar]
  323. Saffhill R. The effect of ionising radiation and chemical methylation upon the activity and accuracy of E. COLI DNA polymerase I. Biochem Biophys Res Commun. 1974 Nov 27;61(2):802–808. doi: 10.1016/0006-291x(74)91028-6. [DOI] [PubMed] [Google Scholar]
  324. Santos E., Tronick S. R., Aaronson S. A., Pulciani S., Barbacid M. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes. Nature. 1982 Jul 22;298(5872):343–347. doi: 10.1038/298343a0. [DOI] [PubMed] [Google Scholar]
  325. Sarasin A. R., Hanawalt P. C. Carcinogens enhance survival of UV-irradiated simian virus 40 in treated monkey kidney cells: induction of a recovery pathway? Proc Natl Acad Sci U S A. 1978 Jan;75(1):346–350. doi: 10.1073/pnas.75.1.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  326. Schendel P. F. Inducible repair systems and their implications for toxicology. Crit Rev Toxicol. 1981 Mar;8(4):311–362. doi: 10.3109/10408448109089902. [DOI] [PubMed] [Google Scholar]
  327. Schwarz J. A., Viaje A., Slaga T. J. Fluocinolone acetonide: a potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesis. Chem Biol Interact. 1977 Jun;17(3):331–347. doi: 10.1016/0009-2797(77)90096-5. [DOI] [PubMed] [Google Scholar]
  328. Scott B. R., Dorn G. L., Käfer E., Stafford R. Aspergillus nidulans: systems and results of tests for induction of mitotic segregation and mutation. II. Haploid assay systems and overall response of all systems. A report of the U.S. EPA Gene-Tox Program. Mutat Res. 1982 Jan;98(1):49–94. doi: 10.1016/0165-1110(82)90003-3. [DOI] [PubMed] [Google Scholar]
  329. Sekiguchi M., Hayakawa H., Makino F., Tanaka K., Okada Y. A human enzyme that liberates uracil from DNA. Biochem Biophys Res Commun. 1976 Nov 22;73(2):293–299. doi: 10.1016/0006-291x(76)90706-3. [DOI] [PubMed] [Google Scholar]
  330. Selikoff I. J., Hammond E. C., Churg J. Asbestos exposure, smoking, and neoplasia. JAMA. 1968 Apr 8;204(2):106–112. [PubMed] [Google Scholar]
  331. Shearman C. W., Loeb L. A. Effects of depurination on the fidelity of DNA synthesis. J Mol Biol. 1979 Feb 25;128(2):197–218. doi: 10.1016/0022-2836(79)90126-8. [DOI] [PubMed] [Google Scholar]
  332. Shelby M. D., Stasiewicz S. Chemicals showing no evidence of carcinogenicity in long-term, two-species rodent studies: the need for short-term test data. Environ Mutagen. 1984;6(6):871–878. doi: 10.1002/em.2860060613. [DOI] [PubMed] [Google Scholar]
  333. Sherr C. J., Fedele L. A., Donner L., Turek L. P. Restriction endonuclease mapping of unintegrated proviral DNA of Snyder-Theilen feline sarcoma virus: localization of sarcoma-specific sequences. J Virol. 1979 Dec;32(3):860–875. doi: 10.1128/jvi.32.3.860-875.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  334. Shih C., Padhy L. C., Murray M., Weinberg R. A. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature. 1981 Mar 19;290(5803):261–264. doi: 10.1038/290261a0. [DOI] [PubMed] [Google Scholar]
  335. Shih C., Shilo B. Z., Goldfarb M. P., Dannenberg A., Weinberg R. A. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5714–5718. doi: 10.1073/pnas.76.11.5714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  336. Shih C., Weinberg R. A. Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell. 1982 May;29(1):161–169. doi: 10.1016/0092-8674(82)90100-3. [DOI] [PubMed] [Google Scholar]
  337. Shilo B. Z., Weinberg R. A. DNA sequences homologous to vertebrate oncogenes are conserved in Drosophila melanogaster. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6789–6792. doi: 10.1073/pnas.78.11.6789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  338. Shimkin M. B., Stoner G. D. Lung tumors in mice: application to carcinogenesis bioassay. Adv Cancer Res. 1975;21:1–58. doi: 10.1016/s0065-230x(08)60970-7. [DOI] [PubMed] [Google Scholar]
  339. Shimkin M. B., Triolo V. A. History of chemical carcinogenesis: some prospective remarks. Prog Exp Tumor Res. 1969;11:1–20. doi: 10.1159/000391385. [DOI] [PubMed] [Google Scholar]
  340. Shinohara K., Cerutti P. A. Excision repair of benzo[a]pyrene-deoxyguanosine adducts in baby hamster kidney 21/C13 cells and in secondary mouse embryo fibroblasts C57BL/6J. Proc Natl Acad Sci U S A. 1977 Mar;74(3):979–983. doi: 10.1073/pnas.74.3.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  341. Shooter K. V. DNA phosphotriesters as indicators of cumulative carcinogen-induced damage. Nature. 1978 Aug 10;274(5671):612–614. doi: 10.1038/274612a0. [DOI] [PubMed] [Google Scholar]
  342. Shubik P. The use of the Syrian golden hamster in chronic toxicity testing. Prog Exp Tumor Res. 1972;16:176–184. doi: 10.1159/000393371. [DOI] [PubMed] [Google Scholar]
  343. Sims P., Grover P. L. Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. Adv Cancer Res. 1974;20:165–274. doi: 10.1016/s0065-230x(08)60111-6. [DOI] [PubMed] [Google Scholar]
  344. Singer B., Brent T. P. Human lymphoblasts contain DNA glycosylase activity excising N-3 and N-7 methyl and ethyl purines but not O6-alkylguanines or 1-alkyladenines. Proc Natl Acad Sci U S A. 1981 Feb;78(2):856–860. doi: 10.1073/pnas.78.2.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  345. Singer B., Kröger M. Participation of modified nucleosides in translation and transcription. Prog Nucleic Acid Res Mol Biol. 1979;23:151–194. doi: 10.1016/s0079-6603(08)60133-6. [DOI] [PubMed] [Google Scholar]
  346. Sirover M. A. Induction of the DNA repair enzyme uracil-DNA glycosylase in stimulated human lymphocytes. Cancer Res. 1979 Jun;39(6 Pt 1):2090–2095. [PubMed] [Google Scholar]
  347. Sirover M. A., Loeb L. A. Metal-induced infidelity during DNA synthesis. Proc Natl Acad Sci U S A. 1976 Jul;73(7):2331–2335. doi: 10.1073/pnas.73.7.2331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  348. Slaga T. J., Fischer S. M., Nelson K., Gleason G. L. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3659–3663. doi: 10.1073/pnas.77.6.3659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  349. Slaga T. J., Klein-Szanto A. J., Triplett L. L., Yotti L. P., Trosko K. E. Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science. 1981 Aug 28;213(4511):1023–1025. doi: 10.1126/science.6791284. [DOI] [PubMed] [Google Scholar]
  350. Slaga T. J. Overview of tumor promotion in animals. Environ Health Perspect. 1983 Apr;50:3–14. doi: 10.1289/ehp.83503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  351. Slater E. E., Anderson M. D., Rosenkranz H. S. Rapid detection of mutagens and carcinogens. Cancer Res. 1971 Jul;31(7):970–973. [PubMed] [Google Scholar]
  352. Snee R. D., Irr J. D. Design of a statistical method for the analysis of mutagenesis at the hypoxanthine-guanine phosphoribosyl transferase locus of cultured Chinese hamster ovary cells. Mutat Res. 1981 Apr;85(2):77–93. doi: 10.1016/0165-1161(81)90023-6. [DOI] [PubMed] [Google Scholar]
  353. Solanki V., Slaga T. J. Specific binding of phorbol ester tumor promoters to intact primary epidermal cells from Sencar mice. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2549–2553. doi: 10.1073/pnas.78.4.2549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  354. Solleveld H. A., Haseman J. K., McConnell E. E. Natural history of body weight gain, survival, and neoplasia in the F344 rat. J Natl Cancer Inst. 1984 Apr;72(4):929–940. [PubMed] [Google Scholar]
  355. Spandidos D. A., Wilkie N. M. Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature. 1984 Aug 9;310(5977):469–475. doi: 10.1038/310469a0. [DOI] [PubMed] [Google Scholar]
  356. Spector D. H., Varmus H. E., Bishop J. M. Nucleotide sequences related to the transforming gene of avian sarcoma virus are present in DNA of uninfected vertebrates. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4102–4106. doi: 10.1073/pnas.75.9.4102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  357. Squire R. A. Ranking animal carcinogens: a proposed regulatory approach. Science. 1981 Nov 20;214(4523):877–880. doi: 10.1126/science.7302565. [DOI] [PubMed] [Google Scholar]
  358. Stara J. F., Mukerjee D., McGaughy R., Durkin P., Dourson M. L. The current use of studies on promoters and cocarcinogens in quantitative risk assessment. Environ Health Perspect. 1983 Apr;50:359–368. doi: 10.1289/ehp.8350359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  359. Stead A. G., Hasselblad V., Creason J. P., Claxton L. Modeling the Ames test. Mutat Res. 1981 Feb;85(1):13–27. doi: 10.1016/0165-1161(81)90282-x. [DOI] [PubMed] [Google Scholar]
  360. Steiner M. E., Woods W. G. Normal formation and repair of gamma-radiation-induced single and double strand DNA breaks in Down syndrome fibroblasts. Mutat Res. 1982 Aug;95(2-3):515–523. doi: 10.1016/0027-5107(82)90282-2. [DOI] [PubMed] [Google Scholar]
  361. Stott W. T., Reitz R. H., Schumann A. M., Watanabe P. G. Genetic and nongenetic events in neoplasia. Food Cosmet Toxicol. 1981 Oct;19(5):567–576. doi: 10.1016/0015-6264(81)90507-1. [DOI] [PubMed] [Google Scholar]
  362. Stott W. T., Watanabe P. G. Differentiation of genetic versus epigenetic mechanisms of toxicity and its application to risk assessment. Drug Metab Rev. 1982;13(5):853–873. doi: 10.3109/03602538208991365. [DOI] [PubMed] [Google Scholar]
  363. Sugimura T., Miwa M. Poly(ADP-ribose) and cancer research. Carcinogenesis. 1983 Dec;4(12):1503–1506. doi: 10.1093/carcin/4.12.1503. [DOI] [PubMed] [Google Scholar]
  364. Sugimura T. Poly(adenosine diphosphate ribose). Prog Nucleic Acid Res Mol Biol. 1973;13:127–151. doi: 10.1016/s0079-6603(08)60102-6. [DOI] [PubMed] [Google Scholar]
  365. Sukumar S., Notario V., Martin-Zanca D., Barbacid M. Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature. 1983 Dec 15;306(5944):658–661. doi: 10.1038/306658a0. [DOI] [PubMed] [Google Scholar]
  366. Sutherland B. M., Harber L. C., Kochevar I. E. Pyrimidine dimer formation and repair in human skin. Cancer Res. 1980 Sep;40(9):3181–3185. [PubMed] [Google Scholar]
  367. Sutherland B. M. Photoreactivating enzyme from human leukocytes. Nature. 1974 Mar 8;248(5444):109–112. doi: 10.1038/248109a0. [DOI] [PubMed] [Google Scholar]
  368. Sutherland B. M., Runge P., Sutherland J. C. DNA photoreactivating enzyme from placental mammals. Origin and characteristics. Biochemistry. 1974 Nov 5;13(23):4710–4715. doi: 10.1021/bi00720a005. [DOI] [PubMed] [Google Scholar]
  369. Tabin C. J., Bradley S. M., Bargmann C. I., Weinberg R. A., Papageorge A. G., Scolnick E. M., Dhar R., Lowy D. R., Chang E. H. Mechanism of activation of a human oncogene. Nature. 1982 Nov 11;300(5888):143–149. doi: 10.1038/300143a0. [DOI] [PubMed] [Google Scholar]
  370. Taparowsky E., Suard Y., Fasano O., Shimizu K., Goldfarb M., Wigler M. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature. 1982 Dec 23;300(5894):762–765. doi: 10.1038/300762a0. [DOI] [PubMed] [Google Scholar]
  371. Tateishi N., Higashi T., Shinya S., Naruse A., Sakamoto Y. Studies on the regulation of glutathione level in rat liver. J Biochem. 1974 Jan;75(1):93–103. doi: 10.1093/oxfordjournals.jbchem.a130387. [DOI] [PubMed] [Google Scholar]
  372. Taylor J. H., Woods P. S., Hughes W. L. THE ORGANIZATION AND DUPLICATION OF CHROMOSOMES AS REVEALED BY AUTORADIOGRAPHIC STUDIES USING TRITIUM-LABELED THYMIDINEE. Proc Natl Acad Sci U S A. 1957 Jan 15;43(1):122–128. doi: 10.1073/pnas.43.1.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  373. Terzaghi M., Little J. B. X-radiation-induced transformation in a C3H mouse embryo-derived cell line. Cancer Res. 1976 Apr;36(4):1367–1374. [PubMed] [Google Scholar]
  374. Thakker D. R., Levin W., Buening M., Yagi H., Lehr R. E., Wood A. W., Conney A. H., Jerina D. M. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides. Cancer Res. 1981 Apr;41(4):1389–1396. [PubMed] [Google Scholar]
  375. Theofilopoulos A. N., Dixon F. J. Immune complexes in human diseases: a review. Am J Pathol. 1980 Aug;100(2):529–594. [PMC free article] [PubMed] [Google Scholar]
  376. Thibodeau L., Verly W. G. Cellular localization of the apurinic/apyrimidinic endodeoxyribonucleases in rat liver. Eur J Biochem. 1980 Jun;107(2):555–563. doi: 10.1111/j.1432-1033.1980.tb06063.x. [DOI] [PubMed] [Google Scholar]
  377. Todo A., Strife A., Fried J., Clarkson B. D. Proliferative kinetics of human hematopoietic cells during different growth phases in vitro. Cancer Res. 1971 Oct;31(10):1330–1340. [PubMed] [Google Scholar]
  378. Topal M. D., Baker M. S. DNA precursor pool: a significant target for N-methyl-N-nitrosourea in C3H/10T1/2 clone 8 cells. Proc Natl Acad Sci U S A. 1982 Apr;79(7):2211–2215. doi: 10.1073/pnas.79.7.2211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  379. Topal M. D., Hutchison C. A., 3rd, Baker M. S. DNA precursors in chemical mutagenesis: a novel application of DNA sequencing. Nature. 1982 Aug 26;298(5877):863–865. doi: 10.1038/298863a0. [DOI] [PubMed] [Google Scholar]
  380. Trosko J. E., Chang C. Genes, pollutants and human diseases. Q Rev Biophys. 1978 Nov;11(4):603–627. doi: 10.1017/s0033583500005680. [DOI] [PubMed] [Google Scholar]
  381. Tsuchiya T., Levy G. Relationship between dose and plateau levels of drugs eliminated by parallel first-order and capacity-limited kinetics. J Pharm Sci. 1972 Apr;61(4):541–544. doi: 10.1002/jps.2600610409. [DOI] [PubMed] [Google Scholar]
  382. Upton A. C. Environmental standards for ionizing radiation: theoretical basis for dose-response curves. Environ Health Perspect. 1983 Oct;52:31–39. doi: 10.1289/ehp.835231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  383. Van De Velde C. J., Van Putten L. M., Zwaveling A. A new metastasizing mammary carcinoma model in mice: model characteristics and applications. Eur J Cancer. 1977 Jun;13(6):555–565. doi: 10.1016/0014-2964(77)90117-7. [DOI] [PubMed] [Google Scholar]
  384. Van Duuren B. L., Sivak A., Segal A., Seidman I., Katz C. Dose-response studies with a pure tumor-promoting agent, phorbol myristate acetate. Cancer Res. 1973 Sep;33(9):2166–2172. [PubMed] [Google Scholar]
  385. Van Ryzin J. Quantitative risk assessment. J Occup Med. 1980 May;22(5):321–326. doi: 10.1097/00043764-198005000-00004. [DOI] [PubMed] [Google Scholar]
  386. Van't Hof J., Schairer L. A. Tradescantia assay system for gaseous mutagens. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res. 1982 Nov;99(3):303–315. [PubMed] [Google Scholar]
  387. Varmus H. E. Form and function of retroviral proviruses. Science. 1982 May 21;216(4548):812–820. doi: 10.1126/science.6177038. [DOI] [PubMed] [Google Scholar]
  388. Veith G. D., Kuehl D. W., Leonard E. N., Puglisi F. A., Lemke A. E. Polychlorinated biphenyls and other organic chemical residues in fish from major watersheds of the United States, 1976. Pestic Monit J. 1979 Jun;13(1):1–11. [PubMed] [Google Scholar]
  389. Veith G. D., Kuehl D. W., Puglisi F. A., Glass G. E., Eaton J. G. Residues of PCB's and DDT in the western Lake Superior ecosystem. Arch Environ Contam Toxicol. 1977;5(4):487–499. doi: 10.1007/BF02220927. [DOI] [PubMed] [Google Scholar]
  390. Verly W. G., Paquette Y. An endonuclease for depurinated DNA in rat liver. Can J Biochem. 1973 Jul;51(7):1003–1009. doi: 10.1139/o73-130. [DOI] [PubMed] [Google Scholar]
  391. Vesell E. S. On the significance of host factors that affect drug disposition. Clin Pharmacol Ther. 1982 Jan;31(1):1–7. doi: 10.1038/clpt.1982.1. [DOI] [PubMed] [Google Scholar]
  392. Vig B. K. Soybean (Glycine max [L.] merrill) as a short-term assay for study of environmental mutagens. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res. 1982 Nov;99(3):339–347. doi: 10.1016/0165-1110(82)90050-1. [DOI] [PubMed] [Google Scholar]
  393. Walford R. L. Multigene families, histocompatibility systems, transformation, meiosis, stem cells, and DNA repair. Mech Ageing Dev. 1979 Jan;9(1-2):19–26. doi: 10.1016/0047-6374(79)90117-9. [DOI] [PubMed] [Google Scholar]
  394. Ward J. F. Some biochemical consequences of the spatial distribution of ionizing radiation-produced free radicals. Radiat Res. 1981 May;86(2):185–195. [PubMed] [Google Scholar]
  395. Ward J. M. Background data and variations in tumor rates of control rats and mice. Prog Exp Tumor Res. 1983;26:241–258. doi: 10.1159/000407263. [DOI] [PubMed] [Google Scholar]
  396. Ward J. M., Goodman D. G., Griesemer R. A., Hardisty J. F., Schueler R. L., Squire R. A., Strandberg J. D. Quality assurance for pathology in rodent carcinogenesis tests. J Environ Pathol Toxicol. 1978 Nov-Dec;2(2):371–378. [PubMed] [Google Scholar]
  397. Ward J. M., Griesemer R. A., Weisburger E. K. The mouse liver tumor as an endpoint in carcinogenesis tests. Toxicol Appl Pharmacol. 1979 Dec;51(3):389–397. doi: 10.1016/0041-008x(79)90363-6. [DOI] [PubMed] [Google Scholar]
  398. Ward J. M., Reznik G. Refinements of rodent pathology and the pathologist's contribution to evaluation of carcinogenesis bioassays. Prog Exp Tumor Res. 1983;26:266–291. doi: 10.1159/000407265. [DOI] [PubMed] [Google Scholar]
  399. Waring M. J. DNA modification and cancer. Annu Rev Biochem. 1981;50:159–192. doi: 10.1146/annurev.bi.50.070181.001111. [DOI] [PubMed] [Google Scholar]
  400. Waters R. Repair of DNA in replicated and unreplicated portions of the human genome. J Mol Biol. 1979 Jan 5;127(1):117–127. doi: 10.1016/0022-2836(79)90462-5. [DOI] [PubMed] [Google Scholar]
  401. Wattenberg L. W. Inhibitors of chemical carcinogens. J Environ Pathol Toxicol. 1980 Mar;3(4 Spec No):35–52. [PubMed] [Google Scholar]
  402. Weinberg G., Ullman B., Martin D. W., Jr Mutator phenotypes in mammalian cell mutants with distinct biochemical defects and abnormal deoxyribonucleoside triphosphate pools. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2447–2451. doi: 10.1073/pnas.78.4.2447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  403. Weinberg R. A. Oncogenes of spontaneous and chemically induced tumors. Adv Cancer Res. 1982;36:149–163. doi: 10.1016/s0065-230x(08)60424-8. [DOI] [PubMed] [Google Scholar]
  404. Weinberg R. A. Oncogenes of spontaneous and chemically induced tumors. Adv Cancer Res. 1982;36:149–163. doi: 10.1016/s0065-230x(08)60424-8. [DOI] [PubMed] [Google Scholar]
  405. Weinstein I. B. Current concepts and controversies in chemical carcinogenesis. J Supramol Struct Cell Biochem. 1981;17(2):99–120. doi: 10.1002/jsscb.380170202. [DOI] [PubMed] [Google Scholar]
  406. Weisburger E. K. History of the Bioassay Program of the National Cancer Institute. Prog Exp Tumor Res. 1983;26:187–201. doi: 10.1159/000407260. [DOI] [PubMed] [Google Scholar]
  407. Weisburger J. H., Williams G. M. Carcinogen testing: current problems and new approaches. Science. 1981 Oct 23;214(4519):401–407. doi: 10.1126/science.7291981. [DOI] [PubMed] [Google Scholar]
  408. Welch K. J., Kuehl D. W., Leonard E. N., Veith G. D., Schoenthal N. D. Background hydrocarbon residues in fishes from the Great Lakes and eastern Montana. Bull Environ Contam Toxicol. 1981 Jun;26(6):724–728. doi: 10.1007/BF01622162. [DOI] [PubMed] [Google Scholar]
  409. Whittemore A. S. The age distribution of human cancer for carcinogenic exposures of varying intensity. Am J Epidemiol. 1977 Nov;106(5):418–432. doi: 10.1093/oxfordjournals.aje.a112484. [DOI] [PubMed] [Google Scholar]
  410. Whittemore A., Altshuller B. Lung cancer incidence in cigarette smokers: further analysis of Doll and Hill's data for British physicians. Biometrics. 1976 Dec;32(4):805–816. [PubMed] [Google Scholar]
  411. Wilkins R. J., Hart R. W. Preferential DNA repair in human cells. Nature. 1974 Jan 4;247(5435):35–36. doi: 10.1038/247035a0. [DOI] [PubMed] [Google Scholar]
  412. Williams G. M. Carcinogen-induced DNA repair in primary rat liver cell cultures; a possible screen for chemical carcinogens. Cancer Lett. 1976 Mar;1(4):231–235. doi: 10.1016/s0304-3835(75)97171-2. [DOI] [PubMed] [Google Scholar]
  413. Witkin E. M. Ultraviolet mutagenesis and inducible DNA repair in Escherichia coli. Bacteriol Rev. 1976 Dec;40(4):869–907. doi: 10.1128/br.40.4.869-907.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  414. Witte O. N., Rosenberg N. E., Baltimore D. A normal cell protein cross-reactive to the major Abelson murine leukaemia virus gene product. Nature. 1979 Oct 4;281(5730):396–398. doi: 10.1038/281396a0. [DOI] [PubMed] [Google Scholar]
  415. Woods W. G., Lopez M., Kalvonjian S. L. Normal repair of gamma radiation-induced single-strand and double-strand DNA breaks in retinoblastoma fibroblasts. Biochim Biophys Acta. 1982 Jul 30;698(1):40–48. doi: 10.1016/0167-4781(82)90182-8. [DOI] [PubMed] [Google Scholar]
  416. Wyrobek A. J., Gordon L. A., Burkhart J. G., Francis M. W., Kapp R. W., Jr, Letz G., Malling H. V., Topham J. C., Whorton M. D. An evaluation of human sperm as indicators of chemically induced alterations of spermatogenic function. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res. 1983 May;115(1):73–148. doi: 10.1016/0165-1110(83)90015-5. [DOI] [PubMed] [Google Scholar]
  417. Yager J. D., Jr, Yager R. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res. 1980 Oct;40(10):3680–3685. [PubMed] [Google Scholar]
  418. Yang S. K., McCourt D. W., Roller P. P., Gelboin H. V. Enzymatic conversion of benzo(a)pyrene leading predominantly to the diol-epoxide r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene through a single enantiomer of r-7, t-8-dihydroxy-7,8-dihydrobenzo(a)pyrene. Proc Natl Acad Sci U S A. 1976 Aug;73(8):2594–2598. doi: 10.1073/pnas.73.8.2594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  419. Yotti L. P., Chang C. C., Trosko J. E. Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science. 1979 Nov 30;206(4422):1089–1091. doi: 10.1126/science.493994. [DOI] [PubMed] [Google Scholar]
  420. Young J. F., Kadlubar F. F. A pharmacokinetic model to predict exposure of the bladder epithelium to urinary N-hydroxyarylamine carcinogens as a function of urine pH, voiding interval, and resorption. Drug Metab Dispos. 1982 Nov-Dec;10(6):641–644. [PubMed] [Google Scholar]
  421. Yunis J. J. The chromosomal basis of human neoplasia. Science. 1983 Jul 15;221(4607):227–236. doi: 10.1126/science.6336310. [DOI] [PubMed] [Google Scholar]
  422. Zimmerman M. R. An experimental study of mummification pertinent to the antiquity of cancer. Cancer. 1977 Sep;40(3):1358–1362. doi: 10.1002/1097-0142(197709)40:3<1358::aid-cncr2820400354>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  423. deBethizy J. D., Sherrill J. M., Rickert D. E., Hamm T. E., Jr Effects of pectin-containing diets on the hepatic macromolecular covalent binding of 2,6-dinitro-[3H]toluene in Fischer-344 rats. Toxicol Appl Pharmacol. 1983 Jul;69(3):369–376. doi: 10.1016/0041-008x(83)90260-0. [DOI] [PubMed] [Google Scholar]
  424. zur Hausen H., O'Neill F. J., Freese U. K., Hecker E. Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature. 1978 Mar 23;272(5651):373–375. doi: 10.1038/272373a0. [DOI] [PubMed] [Google Scholar]
  425. zur Hausen H. The role of viruses in human tumors. Adv Cancer Res. 1980;33:77–107. doi: 10.1016/s0065-230x(08)60669-7. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES